,cell_type,tissue
0,22Rv1,prostate gland
1,22Rv1 treated with 10 nM 17?-hydroxy-5?-androstan-3-one for 4 hours,prostate gland
2,8988T,pancreas
3,A172,brain
4,A549,lung
5,A549 treated with 0.02% ethanol for 1 hour,lung
6,A549 treated with 100 nM dexamethasone for 1 hour,lung
7,A673,musculature of body
8,ACC112,exocrine gland
9,ACHN,kidney
10,activated B cell male adult 22 years treated with 0.5 ?M CpG ODN for 24 hours,bodily fluid
11,activated CD4-positive; alpha-beta memory T cell male adult 43 years treated with 10 ng/mL Interleukin-2 ; anti-CD3 and anti-CD28 coated beads,blood
12,activated CD4-positive; alpha-beta memory T cell male adult 43 years treated with anti-CD3 and anti-CD28 coated beads,blood
13,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour,blood
14,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL Interleukin-4 for 1 hour,blood
15,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL TNF-alpha for 1 hour,blood
16,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 50 U/mL Interleukin-2 for 1 hour,blood
17,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours,blood
18,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL Interleukin-23 for 24 hours; 100 ng/mL Interleukin-1b for 24 hours,blood
19,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL Interleukin-2 for 24 hours,blood
20,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL Interleukin-4 for 24 hours,blood
21,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-12 subunit alpha for 48 hours; 100 ng/mL Interleukin-12 subunit beta for 48 hours,blood
22,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-15 for 48 hours,blood
23,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-2 for 48 hours,blood
24,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL TNF-alpha for 48 hours,blood
25,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours,blood
26,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL Interleukin-12 subunit alpha for 4 hours; 100 ng/mL Interleukin-12 subunit beta for 4 hours,blood
27,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL Interleukin-23 for 4 hours; 100 ng/mL Interleukin-1b for 4 hours,blood
28,activated CD4-positive; alpha-beta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 50 U/mL Interleukin-2 for 4 hours,blood
29,activated CD4-positive; alpha-beta T cell female adult 37 years,blood
30,activated CD4-positive; alpha-beta T cell female adult 37 years treated with Interleukin-10 for 8 hours,blood
31,activated CD4-positive; alpha-beta T cell female adult 37 years treated with Interleukin-4 for 8 hours,blood
32,activated CD4-positive; alpha-beta T cell female adult 37 years treated with Interleukin-6 for 8 hours,blood
33,activated CD4-positive; alpha-beta T cell male adult 20 years treated with 10 ng/mL Interleukin-2 ; anti-CD3 and anti-CD28 coated beads,blood
34,activated CD4-positive; alpha-beta T cell male adult 20 years treated with anti-CD3 and anti-CD28 coated beads,blood
35,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour,blood
36,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL Interleukin-15 for 1 hour,blood
37,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL Interleukin-23 for 1 hour; 100 ng/mL Interleukin-1b for 1 hour,blood
38,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL Interleukin-4 for 1 hour,blood
39,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL TNF-alpha for 1 hour,blood
40,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours,blood
41,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL Interleukin-12 subunit alpha for 24 hours; 100 ng/mL Interleukin-12 subunit beta for 24 hours,blood
42,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL Interleukin-15 for 24 hours,blood
43,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL Interleukin-23 for 24 hours; 100 ng/mL Interleukin-1b for 24 hours,blood
44,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL Interleukin-2 for 24 hours,blood
45,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL Interleukin-4 for 24 hours,blood
46,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL TNF-alpha for 24 hours,blood
47,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 50 U/mL Interleukin-2 for 24 hours,blood
48,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours,blood
49,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-12 subunit alpha for 48 hours; 100 ng/mL Interleukin-12 subunit beta for 48 hours,blood
50,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-15 for 48 hours,blood
51,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-23 for 48 hours; 100 ng/mL Interleukin-1b for 48 hours,blood
52,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-2 for 48 hours,blood
53,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-4 for 48 hours,blood
54,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL TNF-alpha for 48 hours,blood
55,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours,blood
56,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL Interleukin-12 subunit alpha for 4 hours; 100 ng/mL Interleukin-12 subunit beta for 4 hours,blood
57,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL Interleukin-23 for 4 hours; 100 ng/mL Interleukin-1b for 4 hours,blood
58,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL Interleukin-2 for 4 hours,blood
59,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL Interleukin-4 for 4 hours,blood
60,activated CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL TNF-alpha for 4 hours,blood
61,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL Interleukin-15 for 1 hour,blood
62,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL Interleukin-23 for 1 hour; 100 ng/mL Interleukin-1b for 1 hour,blood
63,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL TNF-alpha for 1 hour,blood
64,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 50 U/mL Interleukin-2 for 1 hour,blood
65,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL Interleukin-23 for 24 hours; 100 ng/mL Interleukin-1b for 24 hours,blood
66,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL Interleukin-2 for 24 hours,blood
67,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL Interleukin-4 for 24 hours,blood
68,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL TNF-alpha for 24 hours,blood
69,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 50 U/mL Interleukin-2 for 24 hours,blood
70,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours,blood
71,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-12 subunit alpha for 48 hours; 100 ng/mL Interleukin-12 subunit beta for 48 hours,blood
72,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-23 for 48 hours; 100 ng/mL Interleukin-1b for 48 hours,blood
73,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-2 for 48 hours,blood
74,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-4 for 48 hours,blood
75,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL TNF-alpha for 48 hours,blood
76,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 50 U/mL Interleukin-2 for 48 hours,blood
77,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours,blood
78,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL Interleukin-12 subunit alpha for 4 hours; 100 ng/mL Interleukin-12 subunit beta for 4 hours,blood
79,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL Interleukin-4 for 4 hours,blood
80,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL TNF-alpha for 4 hours,blood
81,activated CD4-positive; alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 50 U/mL Interleukin-2 for 4 hours,blood
82,activated CD4 positive; naive alpha-beta T cell male adult 43 years treated with 10 ng/mL Interleukin-2 ; anti-CD3 and anti-CD28 coated beads,blood
83,activated CD4 positive; naive alpha-beta T cell male adult 43 years treated with anti-CD3 and anti-CD28 coated beads,blood
84,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour,blood
85,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL Interleukin-2 for 1 hour,blood
86,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL Interleukin-4 for 1 hour,blood
87,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL Interleukin-7 for 1 hour,blood
88,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 50 U/mL Interleukin-2 for 1 hour,blood
89,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours,blood
90,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL Interleukin-4 for 24 hours,blood
91,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours,blood
92,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-15 for 48 hours,blood
93,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-2 for 48 hours,blood
94,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-4 for 48 hours,blood
95,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-7 for 48 hours,blood
96,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 50 U/mL Interleukin-2 for 48 hours,blood
97,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours,blood
98,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL Interleukin-12 subunit alpha for 4 hours; 100 ng/mL Interleukin-12 subunit beta for 4 hours,blood
99,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL Interleukin-15 for 4 hours,blood
100,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL Interleukin-4 for 4 hours,blood
101,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL Interleukin-7 for 4 hours,blood
102,activated CD8-positive; alpha-beta memory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 50 U/mL Interleukin-2 for 4 hours,blood
103,activated CD8-positive; alpha-beta memory T cell male adult 30 years treated with 10 ng/mL Interleukin-2 ; anti-CD3 and anti-CD28 coated beads,blood
104,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour,blood
105,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL Interleukin-12 subunit alpha for 1 hour; 100 ng/mL Interleukin-12 subunit beta for 1 hour,blood
106,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL Interleukin-15 for 1 hour,blood
107,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL Interleukin-2 for 1 hour,blood
108,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL Interleukin-4 for 1 hour,blood
109,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 100 ng/mL Interleukin-7 for 1 hour,blood
110,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours,blood
111,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL Interleukin-12 subunit alpha for 24 hours; 100 ng/mL Interleukin-12 subunit beta for 24 hours,blood
112,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL Interleukin-15 for 24 hours,blood
113,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 100 ng/mL Interleukin-7 for 24 hours,blood
114,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 50 U/mL Interleukin-2 for 24 hours,blood
115,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours,blood
116,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-15 for 48 hours,blood
117,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-2 for 48 hours,blood
118,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-4 for 48 hours,blood
119,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 100 ng/mL Interleukin-7 for 48 hours,blood
120,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 50 U/mL Interleukin-2 for 48 hours,blood
121,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours,blood
122,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL Interleukin-15 for 4 hours,blood
123,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL Interleukin-4 for 4 hours,blood
124,activated CD8-positive; alpha-beta memory T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 100 ng/mL Interleukin-7 for 4 hours,blood
125,activated CD8-positive; alpha-beta T cell male adult 21 years treated with 10 ng/mL Interleukin-2 ; anti-CD3 and anti-CD28 coated beads,blood
126,activated CD8-positive; alpha-beta T cell male adult 21 years treated with anti-CD3 and anti-CD28 coated beads,blood
127,activated T-cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 50 U/mL Interleukin-2 for 1 hour,blood
128,activated T-cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours; 50 U/mL Interleukin-2 for 24 hours,blood
129,activated T-cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours; 50 U/mL Interleukin-2 for 48 hours,blood
130,activated T-cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours; 50 U/mL Interleukin-2 for 4 hours,blood
131,activated T-cell male adult 38 years,bodily fluid
132,activated T-cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour,blood
133,activated T-cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 1 hour; 50 U/mL Interleukin-2 for 1 hour,blood
134,activated T-cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 24 hours,blood
135,activated T-cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 48 hours,blood
136,activated T-cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 4 hours,blood
137,adipocyte,connective tissue
138,adipocyte originated from mesenchymal stem cell,connective tissue
139,adipose tissue tissue male adult 34 years,adipose tissue
140,adrenal gland tissue embryo 96 days,adrenal gland
141,adrenal gland tissue female adult 30 years,endocrine gland
142,adrenal gland tissue female adult 41 years,endocrine gland
143,adrenal gland tissue female adult 47 years,adrenal gland
144,adrenal gland tissue female adult 51 years,adrenal gland
145,adrenal gland tissue female adult 53 years,adrenal gland
146,adrenal gland tissue female child 16 years,adrenal gland
147,adrenal gland tissue female embryo 108 days,adrenal gland
148,adrenal gland tissue female embryo 113 days,adrenal gland
149,adrenal gland tissue female embryo 85 days,adrenal gland
150,adrenal gland tissue male adult 34 years,endocrine gland
151,adrenal gland tissue male adult 37 years,adrenal gland
152,adrenal gland tissue male adult 54 years,adrenal gland
153,adrenal gland tissue male embryo 101 days,adrenal gland
154,adrenal gland tissue male embryo 108 days,adrenal gland
155,adrenal gland tissue male embryo 85 days,adrenal gland
156,adrenal gland tissue male embryo 97 days,adrenal gland
157,AG04449,skin of body
158,AG04450,lung
159,AG08395,connective tissue
160,AG08396,connective tissue
161,AG09309,skin of body
162,AG09319,mouth
163,AG10803,skin of body
164,AG20443,connective tissue
165,Ammon's horn tissue male adult 84 years,brain
166,amnion tissue male embryo 16 weeks,extraembryonic component
167,amniotic epithelial cell,epithelium
168,amniotic stem cell male embryo 15 weeks,extraembryonic component
169,angular gyrus tissue female adult 75 years,brain
170,angular gyrus tissue male adult 81 years,brain
171,aorta tissue female adult 30 years,vasculature
172,aorta tissue female adult 41 years,blood vessel
173,aorta tissue female adult 59 years,blood vessel
174,aorta tissue male adult 34 years,arterial blood vessel
175,ascending aorta tissue female adult 51 years,vasculature
176,ascending aorta tissue female adult 53 years,blood vessel
177,astrocyte,spinal cord
178,astrocyte of the cerebellum,brain
179,astrocyte of the hippocampus,brain
180,astrocyte of the spinal cord,spinal cord
181,B cell,bodily fluid
182,B cell female adult 27 years,bodily fluid
183,B cell female adult 27 years and female adult 43 years,blood
184,B cell female adult 34 years,blood
185,B cell female adult 43 years,blood
186,B cell male adult 21 years,blood
187,B cell male adult 22 years,blood
188,B cell male adult 37 years,bodily fluid
189,BE2C,brain
190,bipolar neuron originated from GM23338 treated with 0.5 ?g/mL doxycycline hyclate for 4 days,brain
191,BJ,penis
192,body of pancreas tissue female adult 51 years,pancreas
193,body of pancreas tissue female adult 53 years,pancreas
194,body of pancreas tissue male adult 37 years,pancreas
195,body of pancreas tissue male adult 54 years,pancreas
196,brain microvascular endothelial cell,vasculature
197,brain organoid female embryo 5 days differentiated 180 days,brain
198,brain pericyte,brain
199,brain tissue embryo 112 days,brain
200,brain tissue embryo 56 days and male embryo 58 days,brain
201,brain tissue embryo 80 days,brain
202,brain tissue female embryo 105 days,brain
203,brain tissue female embryo 109 days,brain
204,brain tissue female embryo 117 days,brain
205,brain tissue female embryo 142 days,brain
206,brain tissue female embryo 17 weeks,brain
207,brain tissue female embryo 85 days,brain
208,brain tissue female embryo 96 days,brain
209,brain tissue male embryo 101 days,brain
210,brain tissue male embryo 104 days,brain
211,brain tissue male embryo 105 days,brain
212,brain tissue male embryo 122 days,brain
213,brain tissue male embryo 72 days and male embryo 76 days,brain
214,breast epithelium tissue female adult 51 years,epithelium
215,breast epithelium tissue female adult 53 years,breast
216,breast epithelium tissue male adult 37 years,epithelium
217,breast epithelium tissue male adult 54 years,epithelium
218,bronchial epithelial cell,lung
219,bronchial epithelial cell female treated with 6 ?M retinoic acid for 48 hours,epithelium
220,C4-2B,prostate gland
221,C803,epithelium
222,Caco-2,intestine
223,Caki2,epithelium
224,cardiac fibroblast,heart
225,cardiac fibroblast female adult,heart
226,cardiac fibroblast female embryo 94 days and female embryo 98 days,heart
227,cardiac muscle cell,musculature of body
228,cardiac muscle cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days; 10 ng/mL Bone morphogenetic protein 4 for 14 days; 6 ng/mL Activin A for 14 days,heart
229,cardiac muscle cell originated from RUES2,musculature of body
230,cardiac myoblast originated from H7 treated with 10 ng/mL Bone morphogenetic protein 4 for 9 days; 5 ng/mL Fibroblast growth factor 2 for 9 days; 6 ng/mL Activin A for 9 days,heart
231,cardiac septum tissue female adult 41 years,heart
232,cardiovascular progenitor cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 5 days; 10 ng/mL Bone morphogenetic protein 4 for 5 days; 6 ng/mL Activin A for 5 days,fibroblast
233,caudate nucleus tissue female adult 75 years,brain
234,caudate nucleus tissue male adult 78 years,brain
235,caudate nucleus tissue male adult 81 years,brain
236,CD14-positive monocyte donor ENCDO258PRN,bodily fluid
237,CD14-positive monocyte donor ENCDO836ICQ,bodily fluid
238,CD14-positive monocyte female adult 34 years,blood
239,CD14-positive monocyte female donor ENCDO265AAA,blood
240,CD14-positive monocyte female donor ENCDO266AAA,blood
241,CD14-positive monocyte male adult 21 years,bodily fluid
242,CD14-positive monocyte male adult 21 years and male adult 40 years,blood
243,CD14-positive monocyte male adult 30 years,bodily fluid
244,CD14-positive monocyte male adult 37 years,bodily fluid
245,CD14-positive monocyte originated from CD14-positive monocyte donor ENCDO157PKH,bodily fluid
246,CD14-positive monocyte originated from CD14-positive monocyte donor ENCDO187BUH,bodily fluid
247,CD14-positive monocyte originated from CD14-positive monocyte donor ENCDO553CCA,bodily fluid
248,CD14-positive monocyte originated from CD14-positive monocyte donor ENCDO922TOC,bodily fluid
249,CD1c-positive myeloid dendritic cell,blood
250,CD4-positive; alpha-beta memory T cell donor ENCDO194EHQ,bodily fluid
251,CD4-positive; alpha-beta memory T cell donor ENCDO258PRN,bodily fluid
252,CD4-positive; alpha-beta memory T cell donor ENCDO553CCA,bodily fluid
253,CD4-positive; alpha-beta memory T cell donor ENCDO688UWB,bodily fluid
254,CD4-positive; alpha-beta memory T cell donor ENCDO922CEJ,bodily fluid
255,CD4-positive; alpha-beta memory T cell male adult 43 years,bodily fluid
256,CD4-positive; alpha-beta memory T cell originated from blood cell,bodily fluid
257,CD4-positive; alpha-beta memory T cell originated from CD4-positive; alpha-beta memory T cell donor ENCDO187BUH,bodily fluid
258,CD4-positive; alpha-beta memory T cell originated from CD4-positive; alpha-beta memory T cell donor ENCDO836ICQ,bodily fluid
259,CD4-positive; alpha-beta memory T cell originated from CD4-positive; alpha-beta memory T cell donor ENCDO922TOC,bodily fluid
260,CD4-positive; alpha-beta memory T cell originated from CD4-positive; alpha-beta memory T cell donor ENCDO976NED,bodily fluid
261,CD4-positive; alpha-beta T cell,bodily fluid
262,CD4-positive; alpha-beta T cell female adult 26 years and female adult 39 years; treated with Interferon alpha-2 for 1 hour,blood
263,CD4-positive; alpha-beta T cell female adult 26 years and female adult 39 years; treated with Interleukin-1 beta for 1 hour,blood
264,CD4-positive; alpha-beta T cell female adult 26 years and female adult 39 years; treated with Interleukin-4 for 1 hour,blood
265,CD4-positive; alpha-beta T cell female adult 26 years treated with Interferon gamma for 1 hour,blood
266,CD4-positive; alpha-beta T cell female adult 26 years treated with Interleukin-15 for 1 hour,blood
267,CD4-positive; alpha-beta T cell female adult 33 years donor ENCDO299FMV,blood
268,CD4-positive; alpha-beta T cell female adult 33 years donor ENCDO412QUR,blood
269,CD4-positive; alpha-beta T cell female adult 37 years,blood
270,CD4-positive; alpha-beta T cell female adult 37 years treated with Interleukin-17A for 4 hours,blood
271,CD4-positive; alpha-beta T cell female adult 37 years treated with Interleukin-6 for 4 hours,blood
272,CD4-positive; alpha-beta T cell female adult 37 years treated with Interleukin-6 for 8 hours,blood
273,CD4-positive; alpha-beta T cell female adult 39 years,blood
274,CD4-positive; alpha-beta T cell female adult 39 years treated with 100 ng/mL Interleukin-2 for 4 hours,blood
275,CD4-positive; alpha-beta T cell female adult 39 years treated with Interleukin-10 for 1 hour,blood
276,CD4-positive; alpha-beta T cell female adult 39 years treated with Interleukin-12 subunit beta for 1 hour; Interleukin-12 subunit alpha for 1 hour,blood
277,CD4-positive; alpha-beta T cell female adult 39 years treated with Interleukin-15 for 4 hours,blood
278,CD4-positive; alpha-beta T cell female adult 39 years treated with Interleukin-17A for 1 hour,blood
279,CD4-positive; alpha-beta T cell female adult 39 years treated with Interleukin-21 for 1 hour,blood
280,CD4-positive; alpha-beta T cell female adult 39 years treated with Interleukin-4 for 4 hours,blood
281,CD4-positive; alpha-beta T cell male adult 20 years,bodily fluid
282,CD4-positive; alpha-beta T cell male adult 21 years,bodily fluid
283,CD4-positive; alpha-beta T cell male adult 21 years treated with 7.5 ?g/kg G-CSF for 4 days,blood
284,CD4-positive; alpha-beta T cell male adult 37 years,blood
285,CD4-positive; alpha-beta T cell male adult 37 years treated with 7.5 ?g/kg G-CSF for 4 days,blood
286,CD4-positive; alpha-beta T cell male adult 38 years,blood
287,CD4-positive; alpha-beta T cell male adult 42 years,blood
288,CD4-positive; alpha-beta T cell treated with phorbol 13-acetate 12-myristate ; ionomycin,bodily fluid
289,CD4-positive; CD25-positive; alpha-beta regulatory T cell donor ENCDO194EHQ,bodily fluid
290,CD4-positive; CD25-positive; alpha-beta regulatory T cell donor ENCDO258PRN,bodily fluid
291,CD4-positive; CD25-positive; alpha-beta regulatory T cell donor ENCDO836ICQ,bodily fluid
292,CD4-positive; CD25-positive; alpha-beta regulatory T cell originated from CD4-positive; CD25-positive; alpha-beta regulatory T cell donor ENCDO922TOC,bodily fluid
293,CD4-positive; CD25-positive; alpha-beta regulatory T cell originated from CD4-positive; CD25-positive; alpha-beta regulatory T cell donor ENCDO976NED,bodily fluid
294,CD4-positive naive resting alpha-beta T cell female adult 25 years,blood
295,CD4-positive naive resting alpha-beta T cell male adult 24 years,blood
296,CD4-positive naive resting alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 16 hours; 50 U/mL Interleukin-2 for 16 hours,blood
297,CD4-positive naive resting alpha-beta T cell male adult 42 years treated with 50 U/mL Interleukin-2 for 16 hours,blood
298,CD4-positive naive resting alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 16 hours; 50 U/mL Interleukin-2 for 16 hours,blood
299,CD4-positive naive resting alpha-beta T cell male adult 43 years,bodily fluid
300,CD8-positive; alpha-beta memory T cell donor ENCDO258PRN,bodily fluid
301,CD8-positive; alpha-beta memory T cell donor ENCDO553CCA,bodily fluid
302,CD8-positive; alpha-beta memory T cell donor ENCDO688UWB,bodily fluid
303,CD8-positive; alpha-beta memory T cell donor ENCDO836ICQ,bodily fluid
304,CD8-positive; alpha-beta memory T cell donor ENCDO922CEJ,bodily fluid
305,CD8-positive; alpha-beta memory T cell male adult 24 years,blood
306,CD8-positive; alpha-beta memory T cell male adult 30 years donor ENCDO166AGR,blood
307,CD8-positive; alpha-beta memory T cell male adult 30 years donor ENCDO739OLY,blood
308,CD8-positive; alpha-beta memory T cell originated from CD8-positive; alpha-beta memory T cell donor ENCDO187BUH,bodily fluid
309,CD8-positive; alpha-beta memory T cell originated from CD8-positive; alpha-beta memory T cell donor ENCDO922TOC,bodily fluid
310,CD8-positive; alpha-beta memory T cell originated from CD8-positive; alpha-beta memory T cell donor ENCDO976NED,bodily fluid
311,CD8-positive; alpha-beta T cell,bodily fluid
312,CD8-positive; alpha-beta T cell female adult 33 years donor ENCDO299FMV,blood
313,CD8-positive; alpha-beta T cell female adult 33 years donor ENCDO412QUR,blood
314,CD8-positive; alpha-beta T cell female adult 34 years,blood
315,CD8-positive; alpha-beta T cell male adult 21 years donor ENCDO123NFT,bodily fluid
316,CD8-positive; alpha-beta T cell male adult 21 years donor ENCDO190HXC,bodily fluid
317,CD8-positive; alpha-beta T cell male adult 21 years donor ENCDO781BMZ,blood
318,CD8-positive; alpha-beta T cell male adult 21 years treated with 7.5 ?g/kg G-CSF for 4 days,blood
319,CD8-positive; alpha-beta T cell male adult 28 years,bodily fluid
320,CD8-positive; alpha-beta T cell male adult 37 years,blood
321,CD8-positive; alpha-beta T cell male adult 38 years,blood
322,CD8-positive; alpha-beta T cell male adult 42 years,blood
323,CD8-positive naive resting alpha-beta T cell male adult 24 years,blood
324,CD8-positive naive resting alpha-beta T cell male adult 30 years donor ENCDO166AGR,blood
325,CD8-positive naive resting alpha-beta T cell male adult 30 years donor ENCDO739OLY,blood
326,CD8-positive naive resting alpha-beta T cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 16 hours; 50 U/mL Interleukin-2 for 16 hours,blood
327,CD8-positive naive resting alpha-beta T cell male adult 56 years,blood
328,central memory CD4-positive; alpha-beta T cell male adult 38 years,blood
329,central memory CD4-positive; alpha-beta T cell male adult 42 years,blood
330,cerebellar cortex tissue male adult 78 years and male adult 84 years,brain
331,cerebellum tissue male adult 27 years and male adult 35 years,brain
332,cerebellum tissue male adult 53 years,brain
333,chorion tissue,extraembryonic component
334,chorion tissue female embryo 40 weeks,extraembryonic component
335,chorion tissue male embryo 16 weeks,extraembryonic component
336,chorionic villus tissue embryo 16 weeks,extraembryonic component
337,chorionic villus tissue female embryo 40 weeks,extraembryonic component
338,chorionic villus tissue male embryo 16 weeks,extraembryonic component
339,chorionic villus tissue male embryo 38 weeks,extraembryonic component
340,choroid plexus epithelial cell,vasculature
341,cingulate gyrus tissue female adult 75 years,brain
342,cingulate gyrus tissue male adult 81 years,brain
343,CMK,blood
344,COLO829,connective tissue
345,colonic mucosa tissue female adult 56 years,intestine
346,colonic mucosa tissue female adult 73 years,intestine
347,colonic mucosa tissue female child 16 years,large intestine
348,common myeloid progenitor; CD34-positive donor ENCDO908ZKJ,bone marrow
349,common myeloid progenitor; CD34-positive donor ENCDO930ZLO,bone marrow
350,common myeloid progenitor; CD34-positive female,bone element
351,common myeloid progenitor; CD34-positive female adult 27 years,bone element
352,common myeloid progenitor; CD34-positive female adult 33 years,bone element
353,common myeloid progenitor; CD34-positive female adult 50 years,bone element
354,common myeloid progenitor; CD34-positive male,bone element
355,common myeloid progenitor; CD34-positive male adult,bone marrow
356,common myeloid progenitor; CD34-positive male adult 23 years,bone element
357,common myeloid progenitor; CD34-positive male adult 36 years,bone element
358,common myeloid progenitor; CD34-positive male adult 37 years,bone element
359,common myeloid progenitor; CD34-positive male adult 42 years,bone element
360,common myeloid progenitor; CD34-positive male adult 43 years,bone element
361,common myeloid progenitor; CD34-positive male adult 49 years,bone element
362,coronary artery tissue female adult 51 years,heart
363,coronary artery tissue female adult 53 years,vasculature
364,CWRU1,connective tissue
365,D341Med,brain
366,D721Med,brain
367,Daoy,brain
368,dedifferentiated amniotic fluid mesenchymal stem cell male embryo 15 weeks,extraembryonic component
369,dermis blood vessel endothelial cell female adult donor ENCDO239AAA,epithelium
370,dermis blood vessel endothelial cell female adult donor ENCDO240AAA,epithelium
371,dermis blood vessel endothelial cell male newborn donor ENCDO241AAA,epithelium
372,dermis blood vessel endothelial cell male newborn donor ENCDO244AAA,epithelium
373,dermis microvascular lymphatic vessel endothelial cell female,epithelium
374,dermis microvascular lymphatic vessel endothelial cell male,epithelium
375,DND-41,bodily fluid
376,DOHH2,
377,dorsolateral prefrontal cortex tissue female adult 74 years with Alzheimer's disease,brain
378,dorsolateral prefrontal cortex tissue female adult 78 years,brain
379,dorsolateral prefrontal cortex tissue female adult 79 years,brain
380,dorsolateral prefrontal cortex tissue female adult 81 years with Alzheimer's disease,brain
381,dorsolateral prefrontal cortex tissue female adult 81 years with Cognitive impairment,brain
382,dorsolateral prefrontal cortex tissue female adult 82 years,brain
383,dorsolateral prefrontal cortex tissue female adult 83 years,brain
384,dorsolateral prefrontal cortex tissue female adult 83 years with mild cognitive impairment,brain
385,dorsolateral prefrontal cortex tissue female adult 84 years,brain
386,dorsolateral prefrontal cortex tissue female adult 85 years with Alzheimer's disease,brain
387,dorsolateral prefrontal cortex tissue female adult 86 years with Alzheimer's disease,brain
388,dorsolateral prefrontal cortex tissue female adult 86 years with Cognitive impairment,brain
389,dorsolateral prefrontal cortex tissue female adult 87 years donor ENCDO423GGP,brain
390,dorsolateral prefrontal cortex tissue female adult 87 years donor ENCDO640RUC,brain
391,dorsolateral prefrontal cortex tissue female adult 87 years with Cognitive impairment; Alzheimer's disease,brain
392,dorsolateral prefrontal cortex tissue female adult 87 years with mild cognitive impairment,brain
393,dorsolateral prefrontal cortex tissue female adult 88 years,brain
394,dorsolateral prefrontal cortex tissue female adult 88 years with Alzheimer's disease,brain
395,dorsolateral prefrontal cortex tissue female adult 88 years with mild cognitive impairment,brain
396,dorsolateral prefrontal cortex tissue female adult 89 years,brain
397,dorsolateral prefrontal cortex tissue female adult 89 years with Alzheimer's disease donor ENCDO830KFO,brain
398,dorsolateral prefrontal cortex tissue female adult 89 years with Alzheimer's disease donor ENCDO853VGZ,brain
399,dorsolateral prefrontal cortex tissue female adult 90 or above years donor ENCDO006DAA,brain
400,dorsolateral prefrontal cortex tissue female adult 90 or above years donor ENCDO101GPB,brain
401,dorsolateral prefrontal cortex tissue female adult 90 or above years donor ENCDO218FFZ,brain
402,dorsolateral prefrontal cortex tissue female adult 90 or above years donor ENCDO250PFZ,brain
403,dorsolateral prefrontal cortex tissue female adult 90 or above years with Alzheimer's disease donor ENCDO201EUI,brain
404,dorsolateral prefrontal cortex tissue female adult 90 or above years with Alzheimer's disease donor ENCDO637GUS,brain
405,dorsolateral prefrontal cortex tissue female adult 90 or above years with Alzheimer's disease donor ENCDO847KYQ,brain
406,dorsolateral prefrontal cortex tissue female adult 90 or above years with Alzheimer's disease donor ENCDO865EMM,brain
407,dorsolateral prefrontal cortex tissue female adult 90 or above years with Cognitive impairment; Alzheimer's disease,brain
408,dorsolateral prefrontal cortex tissue female adult 90 or above years with Cognitive impairment donor ENCDO359XWR,brain
409,dorsolateral prefrontal cortex tissue female adult 90 or above years with Cognitive impairment donor ENCDO448YMQ,brain
410,dorsolateral prefrontal cortex tissue female adult 90 or above years with mild cognitive impairment donor ENCDO033BMB,brain
411,dorsolateral prefrontal cortex tissue female adult 90 or above years with mild cognitive impairment donor ENCDO153NUY,brain
412,dorsolateral prefrontal cortex tissue female adult 90 or above years with mild cognitive impairment donor ENCDO471EKG,brain
413,dorsolateral prefrontal cortex tissue female adult 90 or above years with mild cognitive impairment donor ENCDO634UMA,brain
414,dorsolateral prefrontal cortex tissue female adult 90 or above years with mild cognitive impairment donor ENCDO660TGP,brain
415,dorsolateral prefrontal cortex tissue female adult 90 or above years with mild cognitive impairment donor ENCDO672KST,brain
416,dorsolateral prefrontal cortex tissue female adult 90 or above years with mild cognitive impairment donor ENCDO739EFE,brain
417,dorsolateral prefrontal cortex tissue female adult 90 or above years with mild cognitive impairment donor ENCDO915WZE,brain
418,dorsolateral prefrontal cortex tissue male adult 71 years,brain
419,dorsolateral prefrontal cortex tissue male adult 78 years,brain
420,dorsolateral prefrontal cortex tissue male adult 82 years,brain
421,dorsolateral prefrontal cortex tissue male adult 83 years donor ENCDO592ZWW,brain
422,dorsolateral prefrontal cortex tissue male adult 83 years donor ENCDO736YJH,brain
423,dorsolateral prefrontal cortex tissue male adult 84 years,brain
424,dorsolateral prefrontal cortex tissue male adult 86 years,brain
425,dorsolateral prefrontal cortex tissue male adult 87 years,brain
426,dorsolateral prefrontal cortex tissue male adult 87 years with Cognitive impairment; Alzheimer's disease,brain
427,dorsolateral prefrontal cortex tissue male adult 89 years with mild cognitive impairment,brain
428,dorsolateral prefrontal cortex tissue male adult 90 or above years with mild cognitive impairment,brain
429,duodenal mucosa tissue male adult 59 years,intestine
430,duodenal mucosa tissue male adult 76 years,intestine
431,ecto neural progenitor cell originated from H9,ESC derived
432,ectodermal cell originated from HUES64,embryo
433,effector CD4-positive; alpha-beta T cell female adult 25 years,blood
434,effector CD4-positive; alpha-beta T cell male adult 56 years,blood
435,effector memory CD4-positive; alpha-beta T cell,bodily fluid
436,effector memory CD4-positive; alpha-beta T cell female adult 25 years,blood
437,effector memory CD4-positive; alpha-beta T cell male adult 24 years,blood
438,effector memory CD4-positive; alpha-beta T cell male adult 38 years treated with 50 U/mL Interleukin-2 for 16 hours,blood
439,effector memory CD4-positive; alpha-beta T cell male adult 38 years treated with anti-CD3 and anti-CD28 coated beads for 16 hours; 50 U/mL Interleukin-2 for 16 hours,blood
440,effector memory CD4-positive; alpha-beta T cell male adult 42 years treated with 50 U/mL Interleukin-2 for 16 hours,blood
441,effector memory CD4-positive; alpha-beta T cell male adult 56 years,blood
442,EH,penis
443,EL,penis
444,ELF-1,embryo
445,ELR,penis
446,embryonic facial prominence tissue embryo 53 days and embryo 58 days,embryo
447,endocrine pancreas tissue adult 59 years,pancreas
448,endocrine pancreas tissue male adult 45 years,pancreas
449,endocrine pancreas tissue male adult 46 years,pancreas
450,endodermal cell,embryo
451,endodermal cell originated from endodermal cell,embryo
452,endodermal cell originated from HUES64,embryo
453,endothelial cell of umbilical vein male newborn donor ENCDO342AAA,extraembryonic component
454,endothelial cell of umbilical vein male newborn donor ENCDO551FXN,placenta
455,endothelial cell of umbilical vein newborn,epithelium
456,epidermal melanocyte,epithelium
457,epithelial cell of esophagus,esophagus
458,epithelial cell of prostate,epithelium
459,epithelial cell of prostate male,epithelium
460,epithelial cell of proximal tubule,epithelium
461,esophagus muscularis mucosa tissue female adult 51 years,musculature of body
462,esophagus muscularis mucosa tissue female adult 53 years,esophagus
463,esophagus muscularis mucosa tissue male adult 37 years,esophagus
464,esophagus muscularis mucosa tissue male adult 54 years,esophagus
465,esophagus squamous epithelium tissue female adult 51 years,epithelium
466,esophagus squamous epithelium tissue female adult 53 years,epithelium
467,esophagus squamous epithelium tissue male adult 37 years,esophagus
468,esophagus squamous epithelium tissue male adult 54 years,epithelium
469,esophagus tissue female adult 30 years,esophagus
470,esophagus tissue male adult 34 years,esophagus
471,excitatory neuron,
472,eye tissue embryo 56 days and male embryo 76 days,eye
473,eye tissue female embryo 76 days,eye
474,femur tissue female embryo 98 days,skeleton
475,fibroblast of breast female adult 17 years,breast
476,fibroblast of breast female adult 26 years,breast
477,fibroblast of dermis,skin of body
478,fibroblast of dermis female adult,connective tissue
479,fibroblast of dermis NONE and female adult,skin of body
480,fibroblast of gingiva,mouth
481,fibroblast of lung,lung
482,fibroblast of lung female child 11 years and male adult 45 years donor ENCDO156MSV,lung
483,fibroblast of lung female child 11 years and male adult 45 years donor ENCDO269AAA,lung
484,fibroblast of lung male adult 45 years,lung
485,fibroblast of mammary gland female,connective tissue
486,fibroblast of peridontal ligament male,mouth
487,fibroblast of pulmonary artery,vasculature
488,fibroblast of skin of abdomen male embryo 97 days,connective tissue
489,fibroblast of skin of back male embryo 97 days,connective tissue
490,fibroblast of skin of left quadriceps male embryo 97 days,skin of body
491,fibroblast of skin of right biceps male embryo 97 days,skin of body
492,fibroblast of skin of right quadriceps male embryo 97 days,skin of body
493,fibroblast of skin of scalp male embryo 97 days,skin of body
494,fibroblast of the aortic adventitia female,vasculature
495,fibroblast of the conjunctiva,eye
496,fibroblast of upper back skin male embryo 97 days,connective tissue
497,fibroblast of villous mesenchyme,extraembryonic component
498,forelimb muscle tissue female embryo 108 days,musculature of body
499,foreskin fibroblast male newborn donor ENCDO047TBB,skin of body
500,foreskin fibroblast male newborn donor ENCDO191CQJ,skin of body
501,foreskin fibroblast male newborn donor ENCDO232AAA,skin of body
502,foreskin fibroblast male newborn donor ENCDO666YUN,skin of body
503,foreskin fibroblast male newborn donor ENCDO686OPO,skin of body
504,foreskin keratinocyte male newborn donor ENCDO047TBB,skin of body
505,foreskin keratinocyte male newborn donor ENCDO666YUN,skin of body
506,foreskin keratinocyte male newborn donor ENCDO686OPO,skin of body
507,foreskin melanocyte male newborn donor ENCDO047TBB,penis
508,foreskin melanocyte male newborn donor ENCDO666YUN,penis
509,foreskin melanocyte male newborn donor ENCDO686OPO,penis
510,frontal cortex tissue female adult 67 years and female adult 80 years,brain
511,frontal cortex tissue male adult 27 years and male adult 35 years,brain
512,G401,kidney
513,gamma-delta T cell female adult 33 years treated with 50 U/mL Interleukin-2 for 16 hours,blood
514,gamma-delta T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 16 hours; 50 U/mL Interleukin-2 for 16 hours,blood
515,gastrocnemius medialis tissue female adult 51 years,musculature of body
516,gastrocnemius medialis tissue female adult 53 years,musculature of body
517,gastrocnemius medialis tissue male adult 37 years,musculature of body
518,gastrocnemius medialis tissue male adult 54 years,musculature of body
519,gastroesophageal sphincter tissue female adult 51 years,musculature of body
520,gastroesophageal sphincter tissue female adult 53 years,stomach
521,gastroesophageal sphincter tissue male adult 37 years,musculature of body
522,gastroesophageal sphincter tissue male adult 54 years,stomach
523,germinal center tissue,lymphoid tissue
524,germinal matrix tissue male embryo 20 weeks donor ENCDO026HUZ,brain
525,germinal matrix tissue male embryo 20 weeks donor ENCDO463PIS,brain
526,globus pallidus tissue male adult 78 years and male adult 84 years,brain
527,glomerular endothelial cell,epithelium
528,glomerular visceral epithelial cell child 3 years,epithelium
529,GM03348,connective tissue
530,GM03348 genetically modified using transduction,connective tissue
531,GM03348 genetically modified using transduction treated with 3 ?g/mL doxycycline for 10 days,connective tissue
532,GM04503,connective tissue
533,GM04504,connective tissue
534,GM06990,bodily fluid
535,GM08714,bodily fluid
536,GM10248,blood
537,GM10266,blood
538,GM12801,bodily fluid
539,GM12864,bodily fluid
540,GM12865,bodily fluid
541,GM12872,bodily fluid
542,GM12873,bodily fluid
543,GM12874,bodily fluid
544,GM12875,bodily fluid
545,GM12878,bodily fluid
546,GM12891,blood
547,GM12892,blood
548,GM13976,blood
549,GM13977,blood
550,GM18507,lymphoid tissue
551,GM19238,blood
552,GM19239,blood
553,GM19240,blood
554,GM20000,blood
555,GM23248,limb
556,GM23338,skin of body
557,GM23338 originated from GM23248,skin of body
558,H1,embryo
559,H4,epithelium
560,H54,brain
561,H7,embryo
562,H9,embryo
563,H9 G1 phase genetically modified using stable transfection,embryo
564,H9 G1b phase genetically modified using stable transfection,embryo
565,H9 G2 phase genetically modified using stable transfection,embryo
566,H9 genetically modified using stable transfection,embryo
567,H9 originated from H9,embryo
568,H9 S1 phase genetically modified using stable transfection,embryo
569,HAP-1,bone marrow
570,HCEC 1CT,large intestine
571,HCT116,intestine
572,head of caudate nucleus tissue female adult 77 years,brain
573,head of caudate nucleus tissue female adult 78 years,brain
574,head of caudate nucleus tissue female adult 78 years with mild cognitive impairment,brain
575,head of caudate nucleus tissue female adult 81 years with Alzheimer's disease,brain
576,head of caudate nucleus tissue female adult 82 years donor ENCDO165PNJ,brain
577,head of caudate nucleus tissue female adult 82 years donor ENCDO290OPS,brain
578,head of caudate nucleus tissue female adult 82 years donor ENCDO377QXX,brain
579,head of caudate nucleus tissue female adult 83 years,brain
580,head of caudate nucleus tissue female adult 83 years with mild cognitive impairment,brain
581,head of caudate nucleus tissue female adult 86 years with Cognitive impairment,brain
582,head of caudate nucleus tissue female adult 87 years,brain
583,head of caudate nucleus tissue female adult 87 years with Cognitive impairment; Alzheimer's disease,brain
584,head of caudate nucleus tissue female adult 87 years with mild cognitive impairment,brain
585,head of caudate nucleus tissue female adult 88 years,brain
586,head of caudate nucleus tissue female adult 89 years,brain
587,head of caudate nucleus tissue female adult 89 years with Alzheimer's disease donor ENCDO830KFO,brain
588,head of caudate nucleus tissue female adult 89 years with Alzheimer's disease donor ENCDO853VGZ,brain
589,head of caudate nucleus tissue female adult 89 years with mild cognitive impairment,brain
590,head of caudate nucleus tissue female adult 90 or above years donor ENCDO006DAA,brain
591,head of caudate nucleus tissue female adult 90 or above years donor ENCDO081AHA,brain
592,head of caudate nucleus tissue female adult 90 or above years donor ENCDO218FFZ,brain
593,head of caudate nucleus tissue female adult 90 or above years donor ENCDO980GMJ,brain
594,head of caudate nucleus tissue female adult 90 or above years with Alzheimer's disease donor ENCDO470GFA,brain
595,head of caudate nucleus tissue female adult 90 or above years with Alzheimer's disease donor ENCDO473TSU,brain
596,head of caudate nucleus tissue female adult 90 or above years with Alzheimer's disease donor ENCDO597SRH,brain
597,head of caudate nucleus tissue female adult 90 or above years with Alzheimer's disease donor ENCDO658JXQ,brain
598,head of caudate nucleus tissue female adult 90 or above years with Alzheimer's disease donor ENCDO680UUE,brain
599,head of caudate nucleus tissue female adult 90 or above years with Alzheimer's disease donor ENCDO730UYW,brain
600,head of caudate nucleus tissue female adult 90 or above years with Cognitive impairment; Alzheimer's disease,brain
601,head of caudate nucleus tissue female adult 90 or above years with Cognitive impairment donor ENCDO359XWR,brain
602,head of caudate nucleus tissue female adult 90 or above years with Cognitive impairment donor ENCDO448YMQ,brain
603,head of caudate nucleus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO033BMB,brain
604,head of caudate nucleus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO153NUY,brain
605,head of caudate nucleus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO183VJV,brain
606,head of caudate nucleus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO204VNL,brain
607,head of caudate nucleus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO305GYI,brain
608,head of caudate nucleus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO394ZHU,brain
609,head of caudate nucleus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO539ZHT,brain
610,head of caudate nucleus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO557QXE,brain
611,head of caudate nucleus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO634UMA,brain
612,head of caudate nucleus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO660TGP,brain
613,head of caudate nucleus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO672KST,brain
614,head of caudate nucleus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO746DTM,brain
615,head of caudate nucleus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO853KFT,brain
616,head of caudate nucleus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO880FAU,brain
617,head of caudate nucleus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO915WZE,brain
618,head of caudate nucleus tissue male adult 71 years,brain
619,head of caudate nucleus tissue male adult 73 years with Cognitive impairment; Alzheimer's disease,brain
620,head of caudate nucleus tissue male adult 78 years,brain
621,head of caudate nucleus tissue male adult 80 years with Cognitive impairment; Alzheimer's disease,brain
622,head of caudate nucleus tissue male adult 82 years,brain
623,head of caudate nucleus tissue male adult 83 years,brain
624,head of caudate nucleus tissue male adult 84 years with Cognitive impairment; Alzheimer's disease,brain
625,head of caudate nucleus tissue male adult 84 years with mild cognitive impairment,brain
626,head of caudate nucleus tissue male adult 85 years,brain
627,head of caudate nucleus tissue male adult 86 years donor ENCDO022VWV,brain
628,head of caudate nucleus tissue male adult 86 years donor ENCDO666UNK,brain
629,head of caudate nucleus tissue male adult 87 years donor ENCDO123QRW,brain
630,head of caudate nucleus tissue male adult 87 years donor ENCDO203ASI,brain
631,head of caudate nucleus tissue male adult 87 years with Alzheimer's disease,brain
632,head of caudate nucleus tissue male adult 87 years with Cognitive impairment; Alzheimer's disease,brain
633,head of caudate nucleus tissue male adult 89 years with mild cognitive impairment,brain
634,head of caudate nucleus tissue male adult 90 or above years,brain
635,head of caudate nucleus tissue male adult 90 or above years with mild cognitive impairment donor ENCDO283GDX,brain
636,head of caudate nucleus tissue male adult 90 or above years with mild cognitive impairment donor ENCDO877NVF,brain
637,heart left ventricle tissue female adult 46 years,heart
638,heart left ventricle tissue female adult 51 years,heart
639,heart left ventricle tissue female adult 53 years,heart
640,heart left ventricle tissue female adult 56 years,heart
641,heart left ventricle tissue female adult 59 years,heart
642,heart left ventricle tissue female embryo 101 days and female embryo 103 days,heart
643,heart left ventricle tissue female embryo 136 days,heart
644,heart left ventricle tissue male adult 34 years,heart
645,heart left ventricle tissue male adult 40 years,heart
646,heart left ventricle tissue male adult 43 years,heart
647,heart left ventricle tissue male adult 54 years,heart
648,heart left ventricle tissue male adult 69 years,heart
649,heart left ventricle tissue male child 3 years,heart
650,heart right ventricle tissue female adult 46 years,heart
651,heart right ventricle tissue female adult 56 years,heart
652,heart right ventricle tissue female embryo 101 days and female embryo 103 days,heart
653,heart right ventricle tissue male adult 34 years,heart
654,heart right ventricle tissue male adult 40 years,heart
655,heart right ventricle tissue male adult 43 years,heart
656,heart right ventricle tissue male adult 54 years,heart
657,heart right ventricle tissue male adult 55 years,heart
658,heart right ventricle tissue male adult 61 years,heart
659,heart right ventricle tissue male adult 66 years,heart
660,heart right ventricle tissue male adult 69 years,heart
661,heart right ventricle tissue male child 3 years,heart
662,heart tissue embryo 101 days,heart
663,heart tissue embryo 59 days and female embryo 76 days,heart
664,heart tissue embryo 80 days,heart
665,heart tissue embryo 96 days,heart
666,heart tissue female embryo 103 days,heart
667,heart tissue female embryo 105 days,heart
668,heart tissue female embryo 110 days,heart
669,heart tissue female embryo 116 days and female embryo 98 days,heart
670,heart tissue female embryo 117 days,heart
671,heart tissue female embryo 147 days,heart
672,heart tissue female embryo 91 days,heart
673,heart tissue male adult 27 years and male adult 35 years,heart
674,heart tissue male child 3 years,heart
675,heart tissue male embryo 105 days,heart
676,heart tissue male embryo 110 days,heart
677,heart tissue male embryo 120 days,heart
678,heart tissue male embryo 72 days and male embryo 76 days,heart
679,heart tissue male embryo 91 days,heart
680,heart tissue male embryo 96 days,heart
681,HEK293,epithelium
682,HEK293T,epithelium
683,HeLa-S3,epithelium
684,HeLa-S3 G1b phase,epithelium
685,HeLa-S3 treated with interferon alpha for 4 hours,uterus
686,hematopoietic multipotent progenitor cell donor ENCDO116AAA,blood
687,hematopoietic multipotent progenitor cell donor ENCDO579CCQ,blood
688,hematopoietic multipotent progenitor cell donor ENCDO937OUY,blood
689,hematopoietic multipotent progenitor cell treated with erythropoietin for 20 days; hydrocortisone succinate for 20 days; kit ligand for 20 days; interleukin-3 for 20 days,blood
690,hematopoietic multipotent progenitor cell treated with interleukin-3 for 11 days; kit ligand for 11 days; hydrocortisone succinate for 11 days; erythropoietin for 11 days,blood
691,hematopoietic multipotent progenitor cell treated with interleukin-3 for 13 days; kit ligand for 13 days; hydrocortisone succinate for 13 days; erythropoietin for 13 days,blood
692,hematopoietic multipotent progenitor cell treated with interleukin-3 for 15 days; kit ligand for 15 days; hydrocortisone succinate for 15 days; erythropoietin for 15 days,blood
693,hematopoietic multipotent progenitor cell treated with interleukin-3 for 17 days; kit ligand for 17 days; hydrocortisone succinate for 17 days; erythropoietin for 17 days,blood
694,hematopoietic multipotent progenitor cell treated with interleukin-3 for 18 days; kit ligand for 18 days; hydrocortisone succinate for 18 days; erythropoietin for 18 days,blood
695,hematopoietic multipotent progenitor cell treated with interleukin-3 for 4 days; kit ligand for 4 days; hydrocortisone succinate for 4 days; erythropoietin for 4 days,blood
696,hematopoietic multipotent progenitor cell treated with interleukin-3 for 6 days; kit ligand for 6 days; hydrocortisone succinate for 6 days; erythropoietin for 6 days,blood
697,hematopoietic multipotent progenitor cell treated with interleukin-3 for 8 days; kit ligand for 8 days; hydrocortisone succinate for 8 days; erythropoietin for 8 days,blood
698,hepatic stellate cell female adult 59 years,endocrine gland
699,hepatocyte,epithelium
700,hepatocyte originated from H9,epithelium
701,HepG2,endocrine gland
702,HFF-Myc originated from foreskin fibroblast,penis
703,HFFc6,connective tissue
704,hindlimb muscle tissue male embryo 120 days,musculature of body
705,HK-2,epithelium
706,HL-60,bodily fluid
707,HPDE6-E6E7,pancreas
708,HS-27A,epithelium
709,HS-5,bone marrow
710,HT-29,large intestine
711,HT1080,epithelium
712,HTR-8/SVneo,extraembryonic component
713,HUES48,embryo
714,HUES6,embryo
715,HUES64,embryo
716,HuH-7,epithelium
717,HuH-7.5,epithelium
718,IgD-negative memory B cell,bodily fluid
719,IgD-negative memory B cell originated from IgD-negative memory B cell,bodily fluid
720,immature natural killer cell donor ENCDO157PKH,bone marrow
721,immature natural killer cell donor ENCDO187BUH,bone marrow
722,immature natural killer cell donor ENCDO258PRN,bone marrow
723,immature natural killer cell donor ENCDO553CCA,bone marrow
724,immature natural killer cell donor ENCDO836ICQ,bone marrow
725,immature natural killer cell donor ENCDO922TOC,bone marrow
726,immature natural killer cell donor ENCDO976NED,bone marrow
727,IMR-90,lung
728,inferior parietal cortex tissue male adult 84 years,brain
729,inflammatory macrophage male adult 21 years and male adult 40 years,
730,inflammatory macrophage male adult 21 years and male adult 40 years; treated with lipopolysaccharide for 1 hour,
731,inflammatory macrophage male adult 21 years treated with lipopolysaccharide for 4 hours,
732,iPS-11a,skin of body
733,iPS-15b,skin of body
734,iPS-18a,skin of body
735,iPS-18c,skin of body
736,iPS-20b,skin of body
737,iPS-NIHi11 originated from AG20443,skin of body
738,iPS-NIHi7 originated from AG08395,skin of body
739,iPS DF 19.11,skin of body
740,iPS DF 19.7,penis
741,iPS DF 4.7,penis
742,iPS DF 6.9,penis
743,iris pigment epithelial cell,epithelium
744,Ishikawa treated with 0.02% dimethyl sulfoxide for 1 hour,uterus
745,Ishikawa treated with 10 nM 17?-estradiol for 30 minutes,uterus
746,Ishikawa treated with 600 nM afimoxifene for 30 minutes,uterus
747,islet precursor cell,pancreas
748,Jurkat; Clone E6-1,bodily fluid
749,K562,bodily fluid
750,K562 G1 phase,blood
751,K562 G2 phase,blood
752,K562 treated with 0.05% dimethyl sulfoxide for 72 hours,blood
753,K562 treated with 1 ?M vorinostat for 72 hours,blood
754,K562 treated with 500 ?M sodium butyrate for 72 hours,blood
755,Karpas-422,bodily fluid
756,KBM-7,bone marrow
757,keratinocyte female donor ENCDO268AAA,skin of body
758,keratinocyte female donor ENCDO302AAA,epithelium
759,kidney capillary endothelial cell female embryo 113 days,epithelium
760,kidney epithelial cell,epithelium
761,kidney glomerular epithelial cell male adult 43 years and male adult 62 years,epithelium
762,kidney tissue embryo 59 days and female embryo 59 days,kidney
763,kidney tissue embryo 80 days,kidney
764,kidney tissue female adult 47 years,kidney
765,kidney tissue female embryo 105 days donor ENCDO718LHH,kidney
766,kidney tissue female embryo 105 days donor ENCDO863KZW,kidney
767,kidney tissue female embryo 108 days,kidney
768,kidney tissue female embryo 113 days,kidney
769,kidney tissue female embryo 120 days,kidney
770,kidney tissue female embryo 121 days,kidney
771,kidney tissue female embryo 76 days and male embryo 76 days,kidney
772,kidney tissue female embryo 85 days,kidney
773,kidney tissue male adult 22 years and male adult 27 years and male adult 35 years,kidney
774,kidney tissue male adult 50 years,kidney
775,kidney tissue male adult 67 years,kidney
776,kidney tissue male embryo 105 days,kidney
777,kidney tissue male embryo 85 days,kidney
778,kidney tissue male embryo 87 days,kidney
779,kidney tubule cell female adult 80 years and male adult 62 years,epithelium
780,kidney tubule cell female adult 80 years treated with 5 ?M cisplatin,epithelium
781,KMS-11,bone element
782,KOPT-K1,bodily fluid
783,L1-S8,bone marrow
784,L1-S8R,bone marrow
785,large intestine tissue female embryo 103 days,large intestine
786,large intestine tissue female embryo 105 days,large intestine
787,large intestine tissue female embryo 107 days,large intestine
788,large intestine tissue female embryo 108 days,large intestine
789,large intestine tissue female embryo 110 days,large intestine
790,large intestine tissue female embryo 120 days,large intestine
791,large intestine tissue female embryo 91 days,large intestine
792,large intestine tissue female embryo 98 days,large intestine
793,large intestine tissue male embryo 105 days donor ENCDO171HMD,large intestine
794,large intestine tissue male embryo 105 days donor ENCDO350ZUK,large intestine
795,large intestine tissue male embryo 108 days,intestine
796,large intestine tissue male embryo 113 days,large intestine
797,large intestine tissue male embryo 115 days,large intestine
798,large intestine tissue male embryo 91 days,large intestine
799,layer of hippocampus tissue female adult 75 years,brain
800,layer of hippocampus tissue male adult 73 years,brain
801,layer of hippocampus tissue male adult 81 years,brain
802,left cardiac atrium tissue female adult 59 years,heart
803,left cardiac atrium tissue female embryo 101 days,heart
804,left colon tissue female adult 46 years,large intestine
805,left colon tissue female adult 59 years,large intestine
806,left forelimb tissue male embryo 81 days,skeleton
807,left hindlimb tissue male embryo 81 days,skeleton
808,left kidney tissue female embryo 107 days,kidney
809,left kidney tissue female embryo 110 days,kidney
810,left kidney tissue female embryo 147 days,kidney
811,left kidney tissue female embryo 59 days and male embryo 91 days,kidney
812,left kidney tissue female embryo 87 days,kidney
813,left kidney tissue female embryo 98 days,kidney
814,left kidney tissue male embryo 115 days,kidney
815,left kidney tissue male embryo 87 days,kidney
816,left kidney tissue male embryo 96 days,kidney
817,left lobe of liver tissue male adult 45 years,endocrine gland
818,left lung tissue female child 16 years,lung
819,left lung tissue female embryo 105 days,lung
820,left lung tissue female embryo 107 days,lung
821,left lung tissue female embryo 108 days,lung
822,left lung tissue female embryo 110 days,lung
823,left lung tissue female embryo 117 days,lung
824,left lung tissue female embryo 91 days,lung
825,left lung tissue female embryo 98 days,lung
826,left lung tissue male adult 40 years,lung
827,left lung tissue male embryo 105 days,lung
828,left lung tissue male embryo 113 days,lung
829,left lung tissue male embryo 115 days,lung
830,left lung tissue male embryo 87 days,lung
831,left lung tissue male embryo 91 days,lung
832,left lung tissue male embryo 96 days,lung
833,left renal cortex interstitium tissue male embryo 105 days donor ENCDO171HMD,kidney
834,left renal cortex interstitium tissue male embryo 105 days donor ENCDO378UAU,kidney
835,left renal cortex interstitium tissue male embryo 105 days donor ENCDO513BVP,kidney
836,left renal cortex interstitium tissue male embryo 120 days,kidney
837,left renal pelvis tissue male embryo 105 days donor ENCDO171HMD,kidney
838,left renal pelvis tissue male embryo 105 days donor ENCDO378UAU,kidney
839,left renal pelvis tissue male embryo 105 days donor ENCDO513BVP,kidney
840,left renal pelvis tissue male embryo 120 days,kidney
841,left ventricle myocardium inferior tissue male adult 60 years,heart
842,left ventricle myocardium superior tissue male adult 60 years,heart
843,LHCN-M2,musculature of body
844,limb tissue embryo 53 days and embryo 56 days,limb
845,limb tissue embryo 58 days and embryo 59 days,limb
846,liver tissue embryo 59 days and embryo 80 days,endocrine gland
847,liver tissue female adult 25 years,endocrine gland
848,liver tissue female child 6 years and male adult 32 years,endocrine gland
849,liver tissue female embryo 101 days and female embryo 113 days,endocrine gland
850,liver tissue male adult 31 years,endocrine gland
851,liver tissue male adult 32 years,endocrine gland
852,liver tissue male adult 78 years,endocrine gland
853,LNCAP,prostate gland
854,LNCaP clone FGC,epithelium
855,LNCaP clone FGC treated with 1 nM 17?-hydroxy-17-methylestra-4;9;11-trien-3-one for 12 hours,epithelium
856,LNCAP treated with 10 nM 17?-hydroxy-5?-androstan-3-one for 4 hours,prostate gland
857,Loucy,bodily fluid
858,LoVo,large intestine
859,lower leg skin tissue female adult 51 years,skin of body
860,lower leg skin tissue female adult 53 years,limb
861,lower leg skin tissue male adult 37 years,skin of body
862,lower leg skin tissue male adult 54 years,skin of body
863,lower lobe of left lung tissue female adult 59 years,lung
864,lower lobe of left lung tissue female adult 61 years,lung
865,lower lobe of left lung tissue male adult 60 years,lung
866,lower lobe of right lung tissue male adult 60 years,lung
867,lung microvascular endothelial cell female donor ENCDO237AAA,epithelium
868,lung microvascular endothelial cell female donor ENCDO238AAA,epithelium
869,lung tissue embryo 101 days,lung
870,lung tissue embryo 112 days,lung
871,lung tissue embryo 67 days,lung
872,lung tissue embryo 80 days and male embryo 76 days,lung
873,lung tissue female adult 30 years,lung
874,lung tissue female adult 47 years,lung
875,lung tissue female embryo 108 days,lung
876,lung tissue female embryo 120 days,lung
877,lung tissue female embryo 76 days,lung
878,lung tissue female embryo 85 days,lung
879,lung tissue female embryo 96 days,lung
880,lung tissue male adult 27 years and male adult 35 years,lung
881,lung tissue male child 3 years,lung
882,lung tissue male embryo 103 days,lung
883,lung tissue male embryo 108 days,lung
884,lung tissue male embryo 54 days and male embryo 58 days,lung
885,lung tissue male embryo 82 days,lung
886,M059J,brain
887,mammary epithelial cell female,mammary gland
888,mammary epithelial cell female adult 18 years,mammary gland
889,mammary epithelial cell female adult 50 years,epithelium
890,MCF-7,mammary gland
891,MCF-7 genetically modified using RNAi,epithelium
892,MCF-7 originated from MCF-7,epithelium
893,MCF-7 treated with 100 nM 17?-estradiol for 45 minutes,mammary gland
894,MCF-7 treated with 100 nM estradiol for 1 hour,epithelium
895,MCF-7 treated with 10 mM lactate for 24 hours,epithelium
896,MCF 10A,epithelium
897,MCF 10A treated with 1 ?M tamoxifen for 24 hours,epithelium
898,MCF 10A treated with 1 ?M tamoxifen for 6 hours,epithelium
899,medulla oblongata tissue male adult 78 years and male adult 84 years,brain
900,mesenchymal cell originated from H1,connective tissue
901,mesenchymal stem cell female adult and female adult 41 years and female adult 59 years; originated from adipose tissue,connective tissue
902,mesendoderm originated from H1,embryo
903,mesenteric fat pad tissue female adult 59 years,adipose tissue
904,mesodermal cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 2 days; 6 ng/mL Activin A for 2 days; 10 ng/mL Bone morphogenetic protein 4 for 2 days,embryo
905,mesodermal cell originated from HUES64,embryo
906,MG63,bone element
907,mid-neurogenesis radial glial cells genetically modified using stable transfection originated from H9,ESC derived
908,midbrain tissue male adult 78 years and male adult 84 years,brain
909,middle frontal area 46 tissue female adult 75 years,brain
910,middle frontal area 46 tissue male adult 81 years,brain
911,middle frontal gyrus tissue male adult 78 years,brain
912,MM.1S,bodily fluid
913,mononuclear cell male,blood
914,mucosa of descending colon tissue female adult 61 years,large intestine
915,mucosa of descending colon tissue male adult 26 years,large intestine
916,mucosa of descending colon tissue male adult 40 years,large intestine
917,mucosa of gallbladder tissue female child 16 years,gallbladder
918,mucosa of rectum tissue female adult 50 years,intestine
919,mucosa of rectum tissue female adult 61 years,intestine
920,mucosa of stomach tissue male adult 59 years,stomach
921,muscle layer of colon tissue female adult 56 years,intestine
922,muscle layer of colon tissue female adult 77 years,intestine
923,muscle layer of duodenum tissue male adult 59 years,intestine
924,muscle layer of duodenum tissue male adult 73 years,intestine
925,muscle of arm tissue embryo 101 days,musculature of body
926,muscle of arm tissue female embryo 105 days,musculature of body
927,muscle of arm tissue female embryo 115 days,musculature of body
928,muscle of arm tissue female embryo 120 days,musculature of body
929,muscle of arm tissue female embryo 85 days,musculature of body
930,muscle of arm tissue female embryo 98 days,musculature of body
931,muscle of arm tissue male embryo 101 days,musculature of body
932,muscle of arm tissue male embryo 104 days,musculature of body
933,muscle of arm tissue male embryo 105 days,musculature of body
934,muscle of arm tissue male embryo 113 days,musculature of body
935,muscle of arm tissue male embryo 115 days,musculature of body
936,muscle of arm tissue male embryo 120 days,musculature of body
937,muscle of arm tissue male embryo 127 days,musculature of body
938,muscle of arm tissue male embryo 96 days donor ENCDO220PYT,musculature of body
939,muscle of arm tissue male embryo 96 days donor ENCDO817EKT,musculature of body
940,muscle of arm tissue male embryo 97 days donor ENCDO576LXR,musculature of body
941,muscle of arm tissue male embryo 97 days donor ENCDO597UXW,musculature of body
942,muscle of back tissue female embryo 105 days donor ENCDO766MZV,musculature of body
943,muscle of back tissue female embryo 105 days donor ENCDO863KZW,musculature of body
944,muscle of back tissue female embryo 113 days,musculature of body
945,muscle of back tissue female embryo 115 days,musculature of body
946,muscle of back tissue female embryo 85 days,musculature of body
947,muscle of back tissue female embryo 98 days,musculature of body
948,muscle of back tissue male embryo 101 days,musculature of body
949,muscle of back tissue male embryo 104 days,musculature of body
950,muscle of back tissue male embryo 105 days,musculature of body
951,muscle of back tissue male embryo 108 days,musculature of body
952,muscle of back tissue male embryo 127 days,musculature of body
953,muscle of back tissue male embryo 91 days,musculature of body
954,muscle of back tissue male embryo 96 days donor ENCDO220PYT,musculature of body
955,muscle of back tissue male embryo 96 days donor ENCDO817EKT,musculature of body
956,muscle of back tissue male embryo 97 days,musculature of body
957,muscle of leg tissue female embryo 105 days,musculature of body
958,muscle of leg tissue female embryo 110 days,musculature of body
959,muscle of leg tissue female embryo 113 days,musculature of body
960,muscle of leg tissue female embryo 115 days,musculature of body
961,muscle of leg tissue female embryo 85 days,musculature of body
962,muscle of leg tissue male embryo 101 days,musculature of body
963,muscle of leg tissue male embryo 104 days,musculature of body
964,muscle of leg tissue male embryo 105 days,musculature of body
965,muscle of leg tissue male embryo 115 days,musculature of body
966,muscle of leg tissue male embryo 127 days,musculature of body
967,muscle of leg tissue male embryo 96 days donor ENCDO220PYT,musculature of body
968,muscle of leg tissue male embryo 96 days donor ENCDO817EKT,musculature of body
969,muscle of leg tissue male embryo 97 days donor ENCDO576LXR,musculature of body
970,muscle of leg tissue male embryo 97 days donor ENCDO597UXW,musculature of body
971,muscle of trunk tissue female embryo 113 days,musculature of body
972,muscle of trunk tissue female embryo 115 days,musculature of body
973,muscle of trunk tissue female embryo 120 days,musculature of body
974,muscle of trunk tissue female embryo 121 days,musculature of body
975,myocyte originated from LHCN-M2,musculature of body
976,myoepithelial cell of mammary gland female adult 33 years,mammary gland
977,myoepithelial cell of mammary gland female adult 36 years,mammary gland
978,myotube originated from skeletal muscle myoblast,musculature of body
979,naive B cell donor ENCDO270AAA,blood
980,naive B cell donor ENCDO553CCA,bodily fluid
981,naive B cell donor ENCDO836ICQ,bodily fluid
982,naive B cell originated from naive B cell donor ENCDO187BUH,bodily fluid
983,naive B cell originated from naive B cell donor ENCDO922TOC,bodily fluid
984,naive B cell originated from naive B cell donor ENCDO976NED,bodily fluid
985,naive thymus-derived CD4-positive; alpha-beta T cell donor ENCDO173AAA,blood
986,naive thymus-derived CD4-positive; alpha-beta T cell donor ENCDO194EHQ,bodily fluid
987,naive thymus-derived CD4-positive; alpha-beta T cell donor ENCDO258PRN,bodily fluid
988,naive thymus-derived CD4-positive; alpha-beta T cell donor ENCDO553CCA,bodily fluid
989,naive thymus-derived CD4-positive; alpha-beta T cell donor ENCDO688UWB,bodily fluid
990,naive thymus-derived CD4-positive; alpha-beta T cell donor ENCDO836ICQ,bodily fluid
991,naive thymus-derived CD4-positive; alpha-beta T cell donor ENCDO922CEJ,bodily fluid
992,naive thymus-derived CD4-positive; alpha-beta T cell female adult 35 years,blood
993,naive thymus-derived CD4-positive; alpha-beta T cell male adult 26 years,blood
994,naive thymus-derived CD4-positive; alpha-beta T cell originated from naive thymus-derived CD4-positive; alpha-beta T cell donor ENCDO157PKH,bodily fluid
995,naive thymus-derived CD4-positive; alpha-beta T cell originated from naive thymus-derived CD4-positive; alpha-beta T cell donor ENCDO187BUH,bodily fluid
996,naive thymus-derived CD4-positive; alpha-beta T cell originated from naive thymus-derived CD4-positive; alpha-beta T cell donor ENCDO922TOC,bodily fluid
997,naive thymus-derived CD4-positive; alpha-beta T cell originated from naive thymus-derived CD4-positive; alpha-beta T cell donor ENCDO976NED,bodily fluid
998,naive thymus-derived CD8-positive; alpha-beta T cell donor ENCDO258PRN,bodily fluid
999,naive thymus-derived CD8-positive; alpha-beta T cell donor ENCDO553CCA,bodily fluid
1000,naive thymus-derived CD8-positive; alpha-beta T cell donor ENCDO836ICQ,bodily fluid
1001,naive thymus-derived CD8-positive; alpha-beta T cell originated from naive thymus-derived CD8-positive; alpha-beta T cell donor ENCDO187BUH,bodily fluid
1002,naive thymus-derived CD8-positive; alpha-beta T cell originated from naive thymus-derived CD8-positive; alpha-beta T cell donor ENCDO922TOC,bodily fluid
1003,naive thymus-derived CD8-positive; alpha-beta T cell originated from naive thymus-derived CD8-positive; alpha-beta T cell donor ENCDO976NED,bodily fluid
1004,NAMALWA,blood
1005,NAMALWA treated with Sendai virus for 2 hours,blood
1006,natural killer cell female adult 34 years,blood
1007,natural killer cell male adult 21 years,blood
1008,natural killer cell male adult 37 years,bodily fluid
1009,NB4,bone marrow
1010,NCI-H226,lung
1011,NCI-H460,epithelium
1012,NCI-H929,bone element
1013,nephron organoid female embryo 5 days differentiated 35 days,kidney
1014,nephron organoid female embryo 5 days differentiated 49 days,kidney
1015,nephron organoid female embryo 5 days originated from H9 differentiated 21 days,kidney
1016,neural cell originated from H1,ESC derived
1017,neural crest cell,embryo
1018,neural progenitor cell originated from H9,ESC derived
1019,neuroepithelial stem cell genetically modified using stable transfection originated from H9,embryo
1020,neuron originated from H9,ESC derived
1021,neuronal stem cell originated from H1,embryo
1022,neuronal stem cell originated from H9,embryo
1023,neurosphere embryo 15 weeks originated from ganglionic eminence donor ENCDO280TXL,ESC derived
1024,neurosphere embryo 15 weeks originated from ganglionic eminence donor ENCDO594MAO,ESC derived
1025,neurosphere female embryo 17 weeks originated from cortex,ESC derived
1026,neurosphere female embryo 17 weeks originated from ganglionic eminence,ESC derived
1027,neutrophil,bodily fluid
1028,neutrophil male,bodily fluid
1029,non-pigmented ciliary epithelial cell,epithelium
1030,NT2/D1,gonad
1031,occipital lobe tissue male adult 84 years,brain
1032,OCI-LY1,bone marrow
1033,OCI-LY3,lymph node
1034,OCI-LY7,blood
1035,omental fat pad tissue female adult 51 years,adipose tissue
1036,omental fat pad tissue female adult 53 years,adipose tissue
1037,omental fat pad tissue male adult 37 years,adipose tissue
1038,omental fat pad tissue male adult 54 years,adipose tissue
1039,osteoblast,connective tissue
1040,ovary tissue female adult 30 years,ovary
1041,ovary tissue female adult 41 years,gonad
1042,ovary tissue female adult 46 years,gonad
1043,ovary tissue female adult 47 years,gonad
1044,ovary tissue female adult 51 years,ovary
1045,ovary tissue female adult 53 years,gonad
1046,ovary tissue female adult 59 years,gonad
1047,ovary tissue female adult 61 years,gonad
1048,ovary tissue female embryo,gonad
1049,Panc1,pancreas
1050,pancreas tissue female adult 30 years,pancreas
1051,pancreas tissue female adult 41 years,pancreas
1052,pancreas tissue female adult 47 years,pancreas
1053,pancreas tissue female adult 59 years,pancreas
1054,pancreas tissue female adult 61 years,pancreas
1055,pancreas tissue female child 16 years,pancreas
1056,pancreas tissue male adult 26 years,pancreas
1057,pancreas tissue male adult 34 years,pancreas
1058,pancreas tissue male adult 54 years and male adult 60 years,pancreas
1059,parathyroid adenoma tissue male adult 62 years,paraythroid gland
1060,parathyroid adenoma tissue male adult 65 years,paraythroid gland
1061,PC-3,prostate gland
1062,PC-9,lung
1063,peripheral blood mononuclear cell female adult 28 years,bodily fluid
1064,peripheral blood mononuclear cell male adult 27 years,bodily fluid
1065,peripheral blood mononuclear cell male adult 32 years,bodily fluid
1066,peripheral blood mononuclear cell male adult 39 years,bodily fluid
1067,Peyer's patch tissue female adult 51 years,intestine
1068,Peyer's patch tissue female adult 53 years,intestine
1069,Peyer's patch tissue male adult 37 years,intestine
1070,Peyer's patch tissue male adult 54 years,intestine
1071,placenta tissue embryo,extraembryonic component
1072,placenta tissue embryo 102 days,extraembryonic component
1073,placenta tissue embryo 16 weeks,extraembryonic component
1074,placenta tissue embryo 53 days,extraembryonic component
1075,placenta tissue embryo 56 days and embryo 59 days,extraembryonic component
1076,placenta tissue female embryo 101 days and male embryo 105 days,extraembryonic component
1077,placenta tissue female embryo 105 days,extraembryonic component
1078,placenta tissue female embryo 108 days,extraembryonic component
1079,placenta tissue female embryo 113 days,placenta
1080,placenta tissue female embryo 85 days,extraembryonic component
1081,placenta tissue female embryo donor ENCDO353NXC,extraembryonic component
1082,placenta tissue female embryo donor ENCDO412HAL,extraembryonic component
1083,placenta tissue female embryo donor ENCDO496RNL,extraembryonic component
1084,placenta tissue female embryo donor ENCDO818SNP,extraembryonic component
1085,placenta tissue female embryo donor ENCDO952QED,extraembryonic component
1086,placenta tissue male embryo 16 weeks,extraembryonic component
1087,placenta tissue male embryo 85 days,extraembryonic component
1088,placenta tissue male embryo 91 days,extraembryonic component
1089,placenta tissue male embryo donor ENCDO023YQQ,extraembryonic component
1090,placenta tissue male embryo donor ENCDO225QCT,extraembryonic component
1091,placenta tissue male embryo donor ENCDO384FEJ,extraembryonic component
1092,placenta tissue male embryo donor ENCDO442GWY,extraembryonic component
1093,placenta tissue male embryo donor ENCDO824PZQ,extraembryonic component
1094,placenta tissue male embryo donor ENCDO868MLX,extraembryonic component
1095,placental basal plate tissue female embryo 40 weeks,extraembryonic component
1096,placental basal plate tissue male embryo 38 weeks,extraembryonic component
1097,pons tissue male adult 78 years,brain
1098,posterior cingulate gyrus tissue female adult 75 years,brain
1099,posterior cingulate gyrus tissue female adult 77 years,brain
1100,posterior cingulate gyrus tissue female adult 82 years donor ENCDO165PNJ,brain
1101,posterior cingulate gyrus tissue female adult 82 years donor ENCDO290OPS,brain
1102,posterior cingulate gyrus tissue female adult 84 years,brain
1103,posterior cingulate gyrus tissue female adult 85 years,brain
1104,posterior cingulate gyrus tissue female adult 86 years with Alzheimer's disease,brain
1105,posterior cingulate gyrus tissue female adult 87 years,brain
1106,posterior cingulate gyrus tissue female adult 87 years with Cognitive impairment; Alzheimer's disease,brain
1107,posterior cingulate gyrus tissue female adult 88 years,brain
1108,posterior cingulate gyrus tissue female adult 88 years with Alzheimer's disease,brain
1109,posterior cingulate gyrus tissue female adult 89 years,brain
1110,posterior cingulate gyrus tissue female adult 89 years with Alzheimer's disease,brain
1111,posterior cingulate gyrus tissue female adult 90 or above years donor ENCDO006DAA,brain
1112,posterior cingulate gyrus tissue female adult 90 or above years donor ENCDO218FFZ,brain
1113,posterior cingulate gyrus tissue female adult 90 or above years donor ENCDO242JQO,brain
1114,posterior cingulate gyrus tissue female adult 90 or above years donor ENCDO250PFZ,brain
1115,posterior cingulate gyrus tissue female adult 90 or above years donor ENCDO921LXT,brain
1116,posterior cingulate gyrus tissue female adult 90 or above years donor ENCDO948PMW,brain
1117,posterior cingulate gyrus tissue female adult 90 or above years with Alzheimer's disease donor ENCDO020BIL,brain
1118,posterior cingulate gyrus tissue female adult 90 or above years with Alzheimer's disease donor ENCDO150EBZ,brain
1119,posterior cingulate gyrus tissue female adult 90 or above years with Alzheimer's disease donor ENCDO258GJF,brain
1120,posterior cingulate gyrus tissue female adult 90 or above years with Alzheimer's disease donor ENCDO473TSU,brain
1121,posterior cingulate gyrus tissue female adult 90 or above years with Alzheimer's disease donor ENCDO658JXQ,brain
1122,posterior cingulate gyrus tissue female adult 90 or above years with Alzheimer's disease donor ENCDO680UUE,brain
1123,posterior cingulate gyrus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO170MSG,brain
1124,posterior cingulate gyrus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO204VNL,brain
1125,posterior cingulate gyrus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO343SFL,brain
1126,posterior cingulate gyrus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO394ZHU,brain
1127,posterior cingulate gyrus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO471EKG,brain
1128,posterior cingulate gyrus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO672KST,brain
1129,posterior cingulate gyrus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO893GME,brain
1130,posterior cingulate gyrus tissue female adult 90 or above years with mild cognitive impairment donor ENCDO915WZE,brain
1131,posterior cingulate gyrus tissue male adult 73 years with Cognitive impairment; Alzheimer's disease,brain
1132,posterior cingulate gyrus tissue male adult 78 years,brain
1133,posterior cingulate gyrus tissue male adult 80 years with Cognitive impairment; Alzheimer's disease,brain
1134,posterior cingulate gyrus tissue male adult 82 years,brain
1135,posterior cingulate gyrus tissue male adult 83 years donor ENCDO592ZWW,brain
1136,posterior cingulate gyrus tissue male adult 83 years donor ENCDO736YJH,brain
1137,posterior cingulate gyrus tissue male adult 90 or above years with Alzheimer's disease donor ENCDO197QVG,brain
1138,posterior cingulate gyrus tissue male adult 90 or above years with Alzheimer's disease donor ENCDO921RVK,brain
1139,posterior vena cava tissue female adult 47 years,blood vessel
1140,prostate gland tissue male adult 37 years,prostate gland
1141,prostate gland tissue male adult 54 years,prostate gland
1142,psoas muscle tissue female adult 30 years,musculature of body
1143,psoas muscle tissue female adult 59 years,musculature of body
1144,psoas muscle tissue female adult 61 years,musculature of body
1145,psoas muscle tissue female child 16 years,musculature of body
1146,psoas muscle tissue male adult 27 years and male adult 35 years,musculature of body
1147,psoas muscle tissue male adult 34 years,musculature of body
1148,psoas muscle tissue male child 3 years,musculature of body
1149,pulmonary artery endothelial cell female,epithelium
1150,putamen tissue male adult 78 years,brain
1151,radial glial cell genetically modified using stable transfection originated from H9,embryo
1152,RCC,kidney
1153,RCC 7860,epithelium
1154,rectal smooth muscle tissue tissue female adult 50 years,intestine
1155,regulatory T cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 16 hours; 50 U/mL Interleukin-2 for 16 hours,blood
1156,regulatory T cell female adult 35 years,blood
1157,regulatory T cell male adult 24 years,blood
1158,regulatory T cell male adult 28 years,blood
1159,regulatory T cell male adult 56 years,blood
1160,regulatory T cell originated from blood cell,bodily fluid
1161,renal cortex interstitium tissue female embryo 103 days,kidney
1162,renal cortex interstitium tissue female embryo 120 days,kidney
1163,renal cortex interstitium tissue female embryo 89 days,kidney
1164,renal cortex interstitium tissue female embryo 96 days donor ENCDO613NXA,kidney
1165,renal cortex interstitium tissue female embryo 96 days donor ENCDO870OBN,kidney
1166,renal cortex interstitium tissue male embryo 108 days donor ENCDO014CNM,kidney
1167,renal cortex interstitium tissue male embryo 108 days donor ENCDO132ASK,kidney
1168,renal cortex interstitium tissue male embryo 113 days,kidney
1169,renal cortex interstitium tissue male embryo 127 days,kidney
1170,renal cortex interstitium tissue male embryo 91 days,kidney
1171,renal cortex interstitium tissue male embryo 97 days,kidney
1172,renal cortical epithelial cell,epithelium
1173,renal pelvis tissue female embryo 103 days,kidney
1174,renal pelvis tissue female embryo 105 days,kidney
1175,renal pelvis tissue female embryo 89 days,kidney
1176,renal pelvis tissue female embryo 96 days donor ENCDO613NXA,kidney
1177,renal pelvis tissue female embryo 96 days donor ENCDO870OBN,kidney
1178,renal pelvis tissue male embryo 108 days,kidney
1179,renal pelvis tissue male embryo 113 days,kidney
1180,renal pelvis tissue male embryo 127 days,kidney
1181,renal pelvis tissue male embryo 91 days,kidney
1182,renal pelvis tissue male embryo 97 days,kidney
1183,retina tissue embryo 125 days and male embryo 103 days,eye
1184,retina tissue embryo 74 days and embryo 85 days,eye
1185,retina tissue female embryo 89 days,eye
1186,retinal pigment epithelial cell,eye
1187,right atrium auricular region tissue female adult 51 years,heart
1188,right atrium auricular region tissue female adult 53 years,heart
1189,right cardiac atrium tissue female adult 46 years,heart
1190,right cardiac atrium tissue female adult 59 years,heart
1191,right cardiac atrium tissue male adult 34 years,heart
1192,right cardiac atrium tissue male adult 40 years,heart
1193,right cardiac atrium tissue male adult 60 years,heart
1194,right forelimb tissue male embryo 81 days,skeleton
1195,right hindlimb tissue male embryo 81 days,skeleton
1196,right kidney tissue female embryo 107 days,kidney
1197,right kidney tissue female embryo 117 days,kidney
1198,right kidney tissue female embryo 147 days,kidney
1199,right kidney tissue female embryo 87 days,kidney
1200,right kidney tissue female embryo 98 days,kidney
1201,right kidney tissue male embryo 108 days,kidney
1202,right kidney tissue male embryo 115 days,kidney
1203,right kidney tissue male embryo 87 days,kidney
1204,right kidney tissue male embryo 91 days,kidney
1205,right kidney tissue male embryo 96 days,kidney
1206,right lobe of liver tissue female adult 41 years,endocrine gland
1207,right lobe of liver tissue female adult 47 years,endocrine gland
1208,right lobe of liver tissue female adult 53 years,endocrine gland
1209,right lobe of liver tissue female child 16 years,endocrine gland
1210,right lobe of liver tissue male adult 45 years,endocrine gland
1211,right lung tissue female embryo 105 days,lung
1212,right lung tissue female embryo 107 days,lung
1213,right lung tissue female embryo 108 days,lung
1214,right lung tissue female embryo 110 days,lung
1215,right lung tissue female embryo 117 days,lung
1216,right lung tissue female embryo 91 days,lung
1217,right lung tissue female embryo 98 days,lung
1218,right lung tissue male embryo 105 days,lung
1219,right lung tissue male embryo 115 days,lung
1220,right lung tissue male embryo 87 days,lung
1221,right lung tissue male embryo 96 days,lung
1222,right renal cortex interstitium tissue male embryo 105 days donor ENCDO378UAU,kidney
1223,right renal cortex interstitium tissue male embryo 105 days donor ENCDO513BVP,kidney
1224,right renal cortex interstitium tissue male embryo 120 days,kidney
1225,right renal pelvis tissue male embryo 105 days donor ENCDO171HMD,kidney
1226,right renal pelvis tissue male embryo 105 days donor ENCDO378UAU,kidney
1227,right renal pelvis tissue male embryo 105 days donor ENCDO513BVP,kidney
1228,right renal pelvis tissue male embryo 120 days,kidney
1229,Right ventricle myocardium inferior tissue male adult 60 years,heart
1230,Right ventricle myocardium superior tissue male adult 60 years,heart
1231,RKO,large intestine
1232,RPMI7951,epithelium
1233,RPMI8226,blood
1234,RWPE1,epithelium
1235,RWPE2,epithelium
1236,sciatic nerve tissue female adult 41 years,nerve
1237,sigmoid colon tissue female adult 51 years,intestine
1238,sigmoid colon tissue female adult 53 years,intestine
1239,sigmoid colon tissue male adult 34 years,intestine
1240,sigmoid colon tissue male adult 37 years,intestine
1241,sigmoid colon tissue male adult 54 years,intestine
1242,sigmoid colon tissue male child 3 years,colon
1243,SJCRH30,connective tissue
1244,SJCRH30 originated from SJCRH30,connective tissue
1245,SJSA1,bone element
1246,SJSA1 originated from SJSA1,bone element
1247,SK-MEL-5,epithelium
1248,SK-N-DZ,brain
1249,SK-N-DZ treated with dimethyl sulfoxide for 72 hours,brain
1250,SK-N-MC,brain
1251,SK-N-SH,brain
1252,SK-N-SH treated with 6 ?M all-trans-retinoic acid for 48 hours,brain
1253,skeletal muscle cell,musculature of body
1254,skeletal muscle myoblast,musculature of body
1255,skeletal muscle myoblast male adult 22 years,musculature of body
1256,skeletal muscle satellite cell female adult originated from mesodermal cell,musculature of body
1257,skeletal muscle tissue tissue,musculature of body
1258,skeletal muscle tissue tissue female adult 72 years,musculature of body
1259,skeletal muscle tissue tissue male adult 54 years,musculature of body
1260,skin epidermis tissue female adult 48 years,skin of body
1261,skin epidermis tissue female adult 48 years with basal cell carcinoma,skin of body
1262,skin epidermis tissue female adult 64 years,skin of body
1263,skin epidermis tissue female adult 64 years with squamous cell carcinoma,skin of body
1264,skin epidermis tissue female adult 66 years,skin of body
1265,skin epidermis tissue female adult 71 years,skin of body
1266,skin epidermis tissue female adult 71 years with squamous cell carcinoma,skin of body
1267,skin epidermis tissue female adult 80 years,skin of body
1268,skin epidermis tissue female adult 80 years with squamous cell carcinoma,skin of body
1269,skin epidermis tissue male adult 58 years,skin of body
1270,skin epidermis tissue male adult 58 years with basal cell carcinoma,skin of body
1271,skin epidermis tissue male adult 65 years,skin of body
1272,skin epidermis tissue male adult 65 years with basal cell carcinoma,skin of body
1273,skin epidermis tissue male adult 67 years,skin of body
1274,skin epidermis tissue male adult 67 years with basal cell carcinoma,skin of body
1275,skin epidermis tissue male adult 75 years,skin of body
1276,skin epidermis tissue male adult 75 years with squamous cell carcinoma,skin of body
1277,skin epidermis tissue male adult 77 years,skin of body
1278,skin epidermis tissue male adult 77 years with basal cell carcinoma,skin of body
1279,skin epidermis tissue male adult 78 years,skin of body
1280,skin epidermis tissue male adult 78 years with squamous cell carcinoma,skin of body
1281,skin epidermis tissue male adult 84 years with squamous cell carcinoma,skin of body
1282,skin of body tissue female embryo 82 days,skin of body
1283,small intestine tissue female adult 30 years,intestine
1284,small intestine tissue female embryo 105 days,intestine
1285,small intestine tissue female embryo 107 days,intestine
1286,small intestine tissue female embryo 108 days,intestine
1287,small intestine tissue female embryo 110 days,intestine
1288,small intestine tissue female embryo 120 days,intestine
1289,small intestine tissue female embryo 91 days,intestine
1290,small intestine tissue female embryo 98 days,intestine
1291,small intestine tissue male adult 34 years,intestine
1292,small intestine tissue male child 3 years,intestine
1293,small intestine tissue male embryo 105 days,intestine
1294,small intestine tissue male embryo 108 days,intestine
1295,small intestine tissue male embryo 115 days,intestine
1296,small intestine tissue male embryo 87 days,intestine
1297,small intestine tissue male embryo 91 days,intestine
1298,smooth muscle cell of the brain vasculature female,vasculature
1299,smooth muscle cell originated from H9,musculature of body
1300,spinal cord tissue female embryo 108 days,spinal cord
1301,spinal cord tissue female embryo 113 days,spinal cord
1302,spinal cord tissue female embryo 59 days and male embryo 72 days,spinal cord
1303,spinal cord tissue female embryo 87 days,spinal cord
1304,spinal cord tissue female embryo 89 days,spinal cord
1305,spinal cord tissue male embryo 105 days,spinal cord
1306,spinal cord tissue male embryo 96 days,spinal cord
1307,spleen tissue embryo 112 days,spleen
1308,spleen tissue female adult 20 years and female adult 30 years,immune organ
1309,spleen tissue female adult 30 years,immune organ
1310,spleen tissue female adult 41 years,immune organ
1311,spleen tissue female adult 51 years,spleen
1312,spleen tissue female adult 53 years,spleen
1313,spleen tissue female adult 59 years,spleen
1314,spleen tissue female adult 61 years,spleen
1315,spleen tissue male adult 26 years,immune organ
1316,spleen tissue male adult 34 years,spleen
1317,spleen tissue male adult 37 years,spleen
1318,spleen tissue male adult 54 years,spleen
1319,spleen tissue male child 3 years,immune organ
1320,stomach smooth muscle tissue female adult 84 years,musculature of body
1321,stomach smooth muscle tissue male adult 59 years,musculature of body
1322,stomach tissue embryo 101 days,stomach
1323,stomach tissue female adult 30 years,stomach
1324,stomach tissue female adult 51 years,stomach
1325,stomach tissue female adult 53 years,stomach
1326,stomach tissue female embryo,stomach
1327,stomach tissue female embryo 105 days donor ENCDO766MZV,stomach
1328,stomach tissue female embryo 105 days donor ENCDO863KZW,stomach
1329,stomach tissue female embryo 107 days,stomach
1330,stomach tissue female embryo 108 days,stomach
1331,stomach tissue female embryo 121 days,stomach
1332,stomach tissue female embryo 147 days,stomach
1333,stomach tissue female embryo 96 days donor ENCDO188ZLA,stomach
1334,stomach tissue female embryo 96 days donor ENCDO613NXA,stomach
1335,stomach tissue female embryo 96 days donor ENCDO870OBN,stomach
1336,stomach tissue female embryo 98 days,stomach
1337,stomach tissue male adult 34 years,stomach
1338,stomach tissue male adult 37 years,stomach
1339,stomach tissue male adult 54 years,stomach
1340,stomach tissue male child 3 years,stomach
1341,stomach tissue male embryo 108 days,stomach
1342,stomach tissue male embryo 127 days,stomach
1343,stomach tissue male embryo 58 days and male embryo 76 days,stomach
1344,stomach tissue male embryo 91 days,stomach
1345,stromal cell of bone marrow male,bone marrow
1346,SU-DHL-6,blood
1347,subcutaneous abdominal adipose tissue tissue nuclear fraction female adult 25 years,adipose tissue
1348,subcutaneous abdominal adipose tissue tissue nuclear fraction female adult 41 years,adipose tissue
1349,subcutaneous abdominal adipose tissue tissue nuclear fraction female adult 49 years,adipose tissue
1350,subcutaneous abdominal adipose tissue tissue nuclear fraction female adult 59 years,adipose tissue
1351,subcutaneous abdominal adipose tissue tissue nuclear fraction female adult 81 years,adipose tissue
1352,subcutaneous adipose tissue tissue female adult 53 years,adipose tissue
1353,substantia nigra tissue female adult 75 years,brain
1354,substantia nigra tissue male adult 81 years,brain
1355,superior temporal gyrus tissue male adult 84 years,brain
1356,suppressor macrophage male adult 21 years and male adult 24 years,
1357,suppressor macrophage male adult 21 years and male adult 24 years and male adult 40 years; treated with lipopolysaccharide for 1 hour,
1358,suppressor macrophage male adult 21 years and male adult 40 years,
1359,suppressor macrophage male adult 21 years treated with lipopolysaccharide for 4 hours,
1360,suprapubic skin tissue female adult 51 years,skin of body
1361,suprapubic skin tissue female adult 53 years,skin of body
1362,suprapubic skin tissue male adult 37 years,skin of body
1363,suprapubic skin tissue male adult 54 years,skin of body
1364,SW480,large intestine
1365,T-cell,bodily fluid
1366,T-cell female adult 18 years,blood
1367,T-cell female adult 19 years,blood
1368,T-cell female adult 22 years,blood
1369,T-cell female adult 23 years,blood
1370,T-cell female adult 24 years,blood
1371,T-cell female adult 25 years,blood
1372,T-cell female adult 28 years,blood
1373,T-cell female adult 31 years,blood
1374,T-cell female adult 32 years donor ENCDO473DQU,blood
1375,T-cell female adult 32 years donor ENCDO808WEZ,blood
1376,T-cell female adult 33 years donor ENCDO188AUM,blood
1377,T-cell female adult 33 years donor ENCDO204VTZ,blood
1378,T-cell female adult 33 years donor ENCDO299FMV,blood
1379,T-cell female adult 35 years,blood
1380,T-cell female adult 40 years,blood
1381,T-cell female adult 43 years,blood
1382,T-cell female adult 53 years,blood
1383,T-cell male adult 19 years donor ENCDO654TNZ,blood
1384,T-cell male adult 19 years donor ENCDO737NEB,blood
1385,T-cell male adult 21 years donor ENCDO190HXC,blood
1386,T-cell male adult 21 years donor ENCDO394DKX,blood
1387,T-cell male adult 21 years donor ENCDO865QXP,blood
1388,T-cell male adult 21 years treated with 7.5 ?g/kg G-CSF for 4 days,blood
1389,T-cell male adult 24 years donor ENCDO786GVO,blood
1390,T-cell male adult 24 years donor ENCDO937YKH,blood
1391,T-cell male adult 25 years donor ENCDO240EBF,blood
1392,T-cell male adult 25 years donor ENCDO637QAZ,blood
1393,T-cell male adult 26 years donor ENCDO769UME,blood
1394,T-cell male adult 26 years donor ENCDO838UOH,blood
1395,T-cell male adult 27 years,blood
1396,T-cell male adult 28 years donor ENCDO000TPT,blood
1397,T-cell male adult 28 years donor ENCDO249TXE,blood
1398,T-cell male adult 28 years donor ENCDO256UFN,blood
1399,T-cell male adult 28 years donor ENCDO648MMV,blood
1400,T-cell male adult 30 years donor ENCDO091HDH,blood
1401,T-cell male adult 30 years donor ENCDO656FVT,blood
1402,T-cell male adult 33 years,blood
1403,T-cell male adult 34 years donor ENCDO348MRX,blood
1404,T-cell male adult 34 years donor ENCDO496TPO,blood
1405,T-cell male adult 34 years donor ENCDO712ENO,blood
1406,T-cell male adult 36 years donor ENCDO441UHQ,blood
1407,T-cell male adult 36 years donor ENCDO462FPT,blood
1408,T-cell male adult 37 years donor ENCDO028NGF,bodily fluid
1409,T-cell male adult 37 years donor ENCDO147QAL,blood
1410,T-cell male adult 38 years donor ENCDO323QDI,blood
1411,T-cell male adult 38 years donor ENCDO923WRX,bodily fluid
1412,T-cell male adult 39 years,blood
1413,T-cell male adult 40 years,blood
1414,T-cell male adult 42 years,blood
1415,T-cell male adult 47 years,blood
1416,T-cell male adult 48 years,blood
1417,T-cell male adult 49 years,blood
1418,T-cell male adult 55 years,blood
1419,T-helper 17 cell,blood
1420,T-helper 17 cell female adult 25 years and male adult 30 years,blood
1421,T-helper 17 cell male adult 24 years,blood
1422,T-helper 17 cell male adult 42 years,blood
1423,T-helper 17 cell treated with phorbol 13-acetate 12-myristate ; ionomycin,bodily fluid
1424,T-helper 1 cell donor ENCDO174AAA,blood
1425,T-helper 1 cell donor ENCDO334AAA,blood
1426,T-helper 1 cell female adult 26 years,blood
1427,T-helper 1 cell female adult 33 years treated with 50 U/mL Interleukin-2 for 16 hours,blood
1428,T-helper 1 cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 16 hours,blood
1429,T-helper 1 cell male adult 24 years,blood
1430,T-helper 1 cell male adult 30 years,blood
1431,T-helper 1 cell male adult 33 years,blood
1432,T-helper 1 cell male adult 38 years treated with 50 U/mL Interleukin-2 for 16 hours,blood
1433,T-helper 1 cell male adult 42 years,blood
1434,T-helper 1 cell male adult 42 years treated with anti-CD3 and anti-CD28 coated beads for 16 hours; 50 U/mL Interleukin-2 for 16 hours,blood
1435,T-helper 1 cell male adult 56 years,blood
1436,T-helper 22 cell female adult 25 years,blood
1437,T-helper 2 cell,blood
1438,T-helper 2 cell female adult 26 years,blood
1439,T-helper 2 cell male adult 24 years,blood
1440,T-helper 2 cell male adult 30 years,blood
1441,T-helper 2 cell male adult 33 years,blood
1442,T-helper 2 cell male adult 38 years,blood
1443,T-helper 2 cell male adult 42 years,blood
1444,T-helper 9 cell female adult 25 years,blood
1445,T-helper 9 cell female adult 33 years treated with anti-CD3 and anti-CD28 coated beads for 16 hours; 50 U/mL Interleukin-2 for 16 hours,blood
1446,T47D,epithelium
1447,T47D treated with 0.02% dimethyl sulfoxide for 1 hour,mammary gland
1448,T47D treated with 10 nM 17?-estradiol for 30 minutes,epithelium
1449,T follicular helper cell female adult 25 years,
1450,temporal lobe tissue female adult 75 years,brain
1451,temporal lobe tissue male adult 81 years,brain
1452,testis tissue male adult 37 years,gonad
1453,testis tissue male adult 54 years,testis
1454,testis tissue male embryo donor ENCDO482LIM,gonad
1455,testis tissue male embryo donor ENCDO836UAR,gonad
1456,thoracic aorta tissue male adult 37 years,blood vessel
1457,thoracic aorta tissue male adult 54 years,arterial blood vessel
1458,thymus tissue female embryo,endocrine gland
1459,thymus tissue female embryo 105 days,endocrine gland
1460,thymus tissue female embryo 110 days,thymus
1461,thymus tissue female embryo 113 days,endocrine gland
1462,thymus tissue female embryo 147 days,endocrine gland
1463,thymus tissue female embryo 98 days,endocrine gland
1464,thymus tissue male child 3 years,endocrine gland
1465,thymus tissue male embryo 104 days,endocrine gland
1466,thymus tissue male embryo 108 days,endocrine gland
1467,thymus tissue male embryo 113 days,endocrine gland
1468,thymus tissue male embryo 127 days,endocrine gland
1469,thyroid gland tissue female adult 51 years,endocrine gland
1470,thyroid gland tissue female adult 53 years,thyroid gland
1471,thyroid gland tissue male adult 37 years,thyroid gland
1472,thyroid gland tissue male adult 54 years,thyroid gland
1473,tibial artery tissue female adult 53 years,blood vessel
1474,tibial artery tissue male adult 37 years,vasculature
1475,tibial artery tissue male adult 54 years,arterial blood vessel
1476,tibial nerve tissue female adult 51 years,limb
1477,tibial nerve tissue female adult 53 years,nerve
1478,tibial nerve tissue male adult 37 years,nerve
1479,tibial nerve tissue male adult 54 years,limb
1480,tongue tissue female embryo 59 days and female embryo 76 days,mouth
1481,tongue tissue male embryo 72 days,mouth
1482,transverse colon tissue female adult 51 years,intestine
1483,transverse colon tissue female adult 53 years,colon
1484,transverse colon tissue male adult 37 years,intestine
1485,transverse colon tissue male adult 54 years,colon
1486,trophoblast cell embryo 17 weeks and embryo 18 weeks,extraembryonic component
1487,trophoblast cell embryo 21 weeks,extraembryonic component
1488,trophoblast cell embryo 23 weeks,extraembryonic component
1489,trophoblast cell embryo 39 weeks and embryo 40 weeks,extraembryonic component
1490,trophoblast cell originated from H1,extraembryonic component
1491,trophoblast tissue female embryo 20 weeks,embryo
1492,trophoblast tissue female embryo 40 weeks,embryo
1493,UCSF-4,embryo
1494,umbilical cord tissue embryo 59 days and male embryo 76 days,extraembryonic component
1495,upper lobe of left lung tissue female adult 51 years,lung
1496,upper lobe of left lung tissue female adult 53 years,lung
1497,upper lobe of left lung tissue female adult 61 years,lung
1498,upper lobe of left lung tissue male adult 37 years,lung
1499,upper lobe of left lung tissue male adult 54 years,lung
1500,upper lobe of left lung tissue male adult 60 years,lung
1501,upper lobe of right lung tissue male adult 60 years,lung
1502,ureter tissue female adult 47 years,kidney
1503,urinary bladder tissue male adult 34 years,urinary bladder
1504,urinary bladder tissue male embryo 76 days,urinary bladder
1505,urothelium cell line,epithelium
1506,urothelium cell line treated with UT189 for 1 hour,epithelium
1507,uterus tissue female adult 51 years,uterus
1508,uterus tissue female adult 53 years,uterus
1509,uterus tissue female adult 59 years,uterus
1510,vagina tissue female adult 51 years,vagina
1511,vagina tissue female adult 53 years,vagina
1512,VCaP,epithelium
1513,WERI-Rb-1,eye
1514,WI38,lung
1515,WI38 genetically modified using stable transfection originated from WI38,connective tissue
1516,WI38 genetically modified using stable transfection originated from WI38 treated with 20 nM afimoxifene for 72 hours,connective tissue
1517,WI38 genetically modified using stable transfection treated with 20 nM afimoxifene for 72 hours,lung
